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ABSTRACT
Pyruvate kinase [EC. 2.7.1.40.] is ubiquitous and catalyses the second of the ATP forming
reactions of glycolysis, namely the interconversion of phosphoenolpyruvate to pyruvate with
concomitant phosphotransfer to ADP to form ATP. The enzyme requires one monovalent and two
divalent cations for full activity, one of which is enzyme bound and the others being abstracted to
the nucleotide. The enzyme is considered to be the control point for the lower part of the
glycolytic pathway.
Pyruvate kinases can be allosterically regulated by a number of effectors which bind to the
enzyme at sites distinct from the substrate binding site and modify the enzyme activity. It was
the purpose of this project to attempt to determine the nature of this form of regulation using
site directed mutagenesis to alter residues suspected to be involved in mediating the allosteric
effect.
In this project the pyruvate kinase from the yeast Saccharomyces cerevisiae is used as the
model for an allosterically regulated pyruvate kinase. This yeast has only one gene encoding a
pyruvate kinase (pyk1) which is subject to allosteric control. This gene had been cloned and
sequenced prior to the outset of this project, however the sequence was seen to contain a number
of errors which led me to repeat this process.
The approach adopted in this project was to bverexpress pyruvate kinase on a multicopy yeast
shuttle vector, this facilitated its subsequent purification. It is hoped that this approach will
facilitate the production of very large amounts of protein which can be used for x-ray
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1J Jl_. Ge.neral Introduction
Pyruvate kinase (ATP:pyruvate 2-0-phosphotransferase) [EC. 2.7.1.40.]
catalyses the essentially irreversible reaction;
Mg2+ K+
PHOSPHOENOLPYRUVATE + MgADP + H+ > PYRUVATE + MgATP
The enzyme has an absolute requirement for two Mg2+ and one K+ as
cofactors, one of the Mg2+ ions being found in close association with the
protein, the other being complexed with the nucleotide. The enzyme has a low
nucleotide specificity in that UTP, GTP, CTP, ITP and dADP can all serve as
phosphodonors (Strominger, 1955). The properties of the enzyme have been
recently reviewed (Muirhead, 1987). The precise reaction mechanism has been
studied and will be discussed in considerable detail in section 1.1.8.
Pyruvate kinase catalyses the second of the ATP forming reactions of
glycolysis (fig. 1) and in this respect is the major control point for the lower
part of the pathway. The reaction is essentially irreversible in favour of ATP
formation under physiological conditions. Pyruvate is the first
non-phosphorylated intermediate in the glycolytic pathway and occupies a
central role in metabolism where it may be oxidised to acetyl coenzymeA, its
major fate under aerobic conditions, or reduced to form lactate in the absence
of oxygen. ATP is used in many anabolic cellular processes, in the transport of
molecules across membranes, and in mobility and contractility.
Pyruvate kinases are generally regulated allosterically by effector molecules
which bind to the enzyme at a site distinct from the active site. " These



























Figure 1; The glycolytic pathway.




(GAPDH), PHOSPHOGLYCERATE KINASE(PGK), PHOSPHOGLYCERATE-
MUTASE(PGAM), PYRUVATE KINASE(PK), PYRUVATE CARBOXYLASE
(PC), PHOSPHOENOLPYRUVATE CARBOXYKINASE (PEPCK)
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the pathway. One such activator is fructose-1,6,-bisphosphate (Morris et aL
1986). The enzyme may also be feedback inhibited, for example by
gluconeogenic amino acids, which signal a high concentration of products of
pyruvate metabolism, thus shutting off the enzyme to prevent an unnecessary
accumulation of these metabolites. The enzyme is also sensitive to changes in
pH and is activated by NH4+(Kinderfer et a/, 1986, Rhodes et a/, 1986).
Isoenzymes of pyruvate kinase are found in many organisms, both prokaryotic
as in E. co/i and eukaryotic, as in mammalian systems. These isoenzymes are
generally classified by their differing regulatory properties and will be discussed
in more detail in section 1.1.3.
1.1.2. Sequences of pyruvate kinase
Pyruvate kinase is ubiquitous and has been purified from many sources,
both prokaryotic and eukaryotic. This has recently been reviewed and
discussed in an evolutionary context (Guderley et a/, 1989). In general the
enzyme is a homotetramer of Mr 260,000 although there are some small
species and tissue variations. The only exceptions to this are in the cases of
the anaerobic bacterium Zymomonas mob/iis (Pawluk et a/, 1988) and the
fission yeast Schizosaccharomyces pombe (Duncan et at, 1989). In both of
these cases the molecular weight is approximately half of that of the other
pyruvate kinases and it would be tempting to speculate that these may be
dimeric forms of the enzyme.
The sequences of 12 pyruvate kinases have now been elucidated, these are
illustrated in table 1. In addition some partial peptide sequence has been
obtained from Eschericia coli, Bacillus stearothermophilus and Zymomonas
mobl/is (Speranza et a/, 1989, H.Muirhead and R. Scopes personal















PROTEIN 530 Muirhead et at. ( 1986 )
cDNA 529 Lonberg and Gilbert (1983)
cDNA 530 Noguchi eta/. ( 1985 )
cDNA 530 Noguchi et at (1985)
cDNA 543 Tani et ai (1988 )
cDNA 543 Lone et at. ( 1985 )
cDNA 574 ■ Noguchi et at. ( 1987 )
gDNA 500 McNally et al (1989)
gDNA 526 de Graaf and Visser (1988)
gDNA 526 T. Murcott personal comm.
gDNA 526 T. Murcott personal comm.
Table 1; The known sequenes of pyruvate kinases from different species
and tissues.
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:=> match across all seqs.
:=> conservative substitutions
> catrnl
>ch i c X rn 1
> r a t rn 1
> h urnan 1 i ver
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MS QLEHN IGL3 I FE
M—K RK TK FVS
-TEGLFPRG RK VR VVS
> cat rn 1
> ch ickml
> r a t rn 1
> h urnan 1 i ver
> rat 1iver
> ratrbc




> t r ypanosorne 1
> trypanosomel
> baci11 us
> Zrnob i 1 i s
HAAMADTFLEHMCRLDIDSPPITA-RNTGI ICTIGPASRSVEI LX EM IKSGMNVARLNFS
HAAMAOTFLEHMCRLDIDSEPTIA-RNTGI ICTIGPASRSVOKLX EMIX SGMNVARLNFS
HAAMADTFLEHMCRLDIDSAPITA-PNTGI ICTIGPASRSVEMLXEMI X SGMNVARLNFS
PAAMADTrLEHLCLLDIDSEPVAA—RST31 I AT IGPASRSVGRLXEM IKAGMNIARLNFS
PAAMADTFLEHLCLLDIDSEPVAA—RSTSI I AT 1GPASRSVDRLXEM IX AGMNIARLNFS
PAAMADTFLEHLCLLDIDSEPVAA-RST3I I AT IGPASRSVDRLX EM IX AGMNIARLNFS
HAAMADTFLEHMCRLDIDSAPITA-RNTGI ICTIGPASRSVEMLXEM IX SGMNVARLNFS
LERLTSLN—VVAGSDLRRTSIIGTIGPK TNNPETLVALRK AGLNIVRMNFS
LEWHSK LNTEMVPAK NFRRT3 I I CT I GPK TNSVE.K INALRRAGLNVVRMNFS
LEWHSK LNTEMVPAK NFRRTSI IGTIGPK TNSVEKINALRTAGLNVVRMNFS
PVAKHRANR IVCTI GPSTQSVEAL.XNLMK SGMSVARMNFS
PVAK HRANRIVCTIGPSTQSVEALKNLMK SGMSVARMNFS
TFG PASESV'DK LVQLMEAGMNV'ARNLFS
. * ■ * . «*** , ... . ..
> c a t rn 1
fen i c x rn 1
> r a t m 1
> n urnan 1 i v er
> rat 1iver
fratrbc
























































RTG—NFOGDK DIPI X QG
RTGLFX DGEVSFAPG
RTGLFX OGEVTFAPG
******* * « * * *
Figure 2; Sequence alignement of pyruvate Kinase sequences generated by
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AALK VTLDNAFMENCDENVLWVDYKNLIK V IDVGSK
ATLK I TLDNAYMEK CDEN ILWLDYK N I CK VVEVGSk
SGVLVTVDPAFRTRGNANTVWVDYPN I VRWPVGGR
SGVLVTVDPAFQTRGDAK TVWVDYHN I TRWftV'GGR
SQVLVTVDPAFQTRGDAKTVWVDYHNITRVVAVGGR
ATLK I TLDNAYMEK CDEN I LWLDYK N I CK VVEVGSK
HEM IFTTDDKYAK ACDDKIMYVDYK NITK VISAGRI
HEMNISTDEQYATASDDQNMYVDYK NITK V I3AGK L
HELNITTDEQYATASDDK NMYLDYK NITK V I3AGKL
DIVCVTTDF'AYEKVGTK EK FY IDYPQLTNAVPPGGS
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CNRAGK PV I CATQMLE3M IK K PRPTRAEGSDVANAVLDGADC IML3GETAK GDYF'LEAVP
CNRAGKPI ICATQMLESMIK K FRPTRAEGSDVANAVLDGADCIMLSGETAK GDYPLEAVP




CNRAGK PVICATQMLESMIK K PRPTRAEGSDVANAVLDGADCIMLSGETAK GDYPLEAVR
SNLAGKPVICATQMLESMTYNPRFTRAEVSDVGNAILDGADCVMLSGETAKGNYPINAVT























MQHAIAREAEAAVYHRQLFEELRRAAPL3RDPTEVTA IGAVEASFK CCAAAI I-VLTTTGR
MQHAIAREAEAAVYHRQLrEELRRAAPL3RDPTEVTAIGAVEASFKCCAAAI I-VLTTTGR
MQHLIAREAEAAIYHLQLFEELRRLAPIT3DPTEAAAVGAVEASFKCC3GAI I-VLTkSGR
TMAETAVIAEQAI AYLPNYDDMRNCTPKPTSTTETVAASAVAAVFEQK Ak A I I-VL3T3GT
MMSETCLLAEVAIPHFNVFDELRNLAPRFTOTVESIAMAAVSASLELNAGAIV-VLTTSGN
MMSETCLLAEVAIPHFNVFDELRNLAPRPTDTVESIAMAAV3ASLGLNAGAIV-VLTTSGK
YMAR X CVEAGSATHDTVMFNSIKNLQK IFMCPEEAVCSSAVASAFEVQAKAML—VL3NTGP
YMARICVEAQSATHDTVMFNSIKNLQKIPMCPEEAYCSSAVASAFEVQAKAML-VL3NTGR
Eco 1 i
c a t rn 1
c h l c k rn 1
ratml
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t rypanosome2
cat m 1













3AHLVSRYRPRAPI IAVTRNDQTARQAHLYRGVFPVLCK QPAHO AWAEDVDLRVNL




SAHQVARYRPRAPI IAVTRNPQTARQAHLYRGIFPVLCK DAVLD AWAEDVDLRVNL
TPRLVSKYRPNCPI ILVTRCPRAARFSHLYRGVFPFVF-EKEP VSDWTDDVEAP!NF
TARM ISK YRPVCPI IMVSRNPAATRYSHLYRGVWPFYFPEKK PDFNVK IWQEDVDRRLK W
TARYLSKYRPVCPIVMVTRNPAASRYSHLYRGVWPFYFPEK K PDFNVK VWQEDVDRRLKW
SARL I SK YRPNCP I I CVTTRLQTCRQLNVTRSWSVFYDAAK SGED K DK EK RVK _
SARL I SK YRPNCP I ICVTTRLQTCRQLNVTRSVVSVFYDAAK SGED K DK EK RVkrL
AMNVGK ARGFFKHGDVVIVLTGWRPGSGFTNTMRVVPVP





AMNVGK ARGFFK K GDVVIVL TGWRPGSGFTNTMRVVPVP
GIEK AK EFGILK K GDTYVSIQGFKAGAGHSNTLQVSTV
S I NHGLK LG I INK GDNIVCVQGWRGGMGHTNTVRWPAEENLGLSE
GINHALK LGI INK GDNIVCVQGWRGGMGHTNTVRVVPAEENLGLAE
GLDFAK K EK YASTGDVVVVVHADHSVKGYPNQTRLIYLP
GLDFAK K EK YASTGDVVVVVHADHSVK GYPNQTRLIYLP
Figure 3; (a) Monomer of cat muscle pyruvate kinase (b) Monomer of yeast
pyruvate kinase.
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sequences which was generated using the multiple sequence alignment
program CLUSTAL (Higgins and Sharp, 1988) Partial protein sequences from
E.coli and B.stearothermophi/us have been added later and aligned to the other
sequences by eye. The N terminal sequence of Z.mobilis is inserted but has no
sequence similarity to any of the other pyruvate kinases. In mammalian
systems four different isoenzymes of pyruvate kinase have been demonstrated
and these are illustrated in table 2. Sequence information is available for
examples of each of these different isoenzymes from a number of organisms.
1.1.3. Regu|ation _Qf_Pyruvate kinase
Pyruvate kinases are subject to both coarse and fine control. The
mammalian liver isoenzyme is subject to coarse control by phosphorylation of
a specific serine residue under hormonal control by cAMP dependant protein
kinase. The specific phosphoserine residue has been identified and is located
near the N-terminus of the protein. Phosphorylation at this serine residue
leads to a decrease in the enzyme affinity for PEP and fructose 1,6
bisphosphate, and an increase in the affinity for ATP and alanine with the Vmax
remaining unaffected (Bergstrom et aK 1976), Eckman et at„ 1976). These
changes are reversed by dephosphorylation of the enzyme and sen/e to prevent
a futile loop between glycolysis and gluconeogenesis.
Yeast pyruvate kinase is also reported to be phosphorylated by
cAMP-dependant protein kinase in vitro (Blair and Harman, 1986). Structural
studies reveal that this cannot be at the same position as in liver pyruvate
kinase as the yeast enzyme has a truncated amino terminus and lacks the
corresponding phosphorylated serine residue. Sequencing studies reveal the
presence of a potential cAMP-dependant protein kinase binding site in yeast
pyruvate kinase (Burke et a/, 1983). Phosphorylation appears to activate the
10













Table 2; The four mammlian isoenzymes of pyruvate kinase.
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enzyme, however the authors report that thier results are variable and enzyme
preparation dependant, therefore the physiological significance of this
phosphorylation event, if any, has not been elucidated. Both the liver and yeast
PKs are also subject to fine control by allosteric effectors.
The Ml muscie isoenzyme is reported to be regulated by a reversible
binding to F-actin. There are said to be 4 pyruvate kinase binding sites per
turn of the F-actin helix and binding is reported to decrease enzyme activity by
60% (Chan et a!1986). The Ml isoenzyme is the only isoenzyme so far
reported that is insensitive to all allosteric effectors under physiological
conditions.
Eukaryotic pyruvate kinases from certain sources are subject to fine control
by allosteric effectors, reflecting the different metabolic requirements of the
cells in ,which they are located. These regulated forms are activated by
fructose 1,6 bisphosphate and are inhibited by ATP, gluconeogenic amino acids,
citrate and high pH, Prokaryotic pyruvate kinases are also allosterically
regulated. The gram negative bacterium Eschericia coli has two forms of the
enzyme both of which are subject to allosteric control. One form is
eukaryotic-like in that it is activated by fructose 1,6 bisphosphate while the
other is activated by AMP, ribose-5-phosphate and other nucleoside
monophosphates (Speranza at a/, 1989.) The gram positive, moderate
thermophile, Bacillus stearothermophilus has only one form of the enzyme, that
which is regulated by AMP (Sakai et at, 1986). This would appear to reflect the
different metabolic requirements of prokaryotic cells. While all bacteria so far
studied, including archaebacteria, appear to have a pyruvate kinase, not all of
them utilise the Embden-Mayerhoff pathway of glycolysis as the main pathway
for the catabolism of glucose. Many lower organisms utilise the
Entner-Doudroff pathway and glucose-6-phosphate shunt as mechanisms of
12
glucose catabolism, and thus the enzymes appear to have evolved to respond
to the products of these pathways. The fact that Eco/i has two pyruvate
kinases reflects its ability to undertake both of these metabolic pathways.
The yeast Saccharomyces cerevisiae has only one form of pyruvate kinase
which is 'eukaryotic' in that it is allosterically regulated by fructose-
1,6-bisphosphate, ATP and gluconeogenic amino acids, just as the mammalian
isoenzymes are. The enzyme is encoded by the gene pyk1, located on
chromosome 1 . Yeasts, as lower eukaryotes, have only one pyruvate kinase
which is allosterically regulated. This may be a reflection of their
undifferentiated form.
1,1.4. The structure of pyruvate kinase
An X-ray structure of the M1 isoenzyme of pyruvate kinase from cat muscle
has been elucidated and resolved to 2.6A (Muirhead et at, 1986). Figure 3a
r
illustrates a monomer of pyruvate kinase while figure 4 demonstrates the
tetrameric arrangement of the protein. Each monomer is arranged in four
domains designated N, A, 8, and C as illustrated in figure 5. Domain N runs
from residue 1-42, A from residue 43-115 then 224-387, B from 116-223 and C
from 388-530. The N terminal residues 1-9 cannot be assigned in the electron
density map, probably a reflection of their inherent flexibility. Some of the 8
domain also appears to be disordered. Domain A forms an eight-stranded a/8
barrel, a common element in protein tertiary structure (Richardson, 1981) which
will be discussed in section 1.2 in considerably more detail.
The active site of the protein lies in a cleft between domains A and B, while
the allosteric effectors bind between domains A and C. Figure 6 demonstrates
the positions of the substrates and effectors within the monomer. The
tetrameric protein may be considered to be a dimer of dimers in that there are
13
Figure 4; Tetramer of pyruvate kinase.
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Figure 5; Monomer of cat musle pyruvate kinase illustrating the 4 domains,
A, 8, C and N
15
Figure 6; A monomer of pyruvate kinase is illustrated in the upper diagram,
with the substrates and allosteric effectors in postion. Phosphoenolpyruvate
and ATP are shown in the substrate binding site. ATP is bound in the effector
binding site. The lower figure shows, in close up, the overlapping phosphates
of ATP and PEP. The side chain of lysine 269 is shown in blue. This is
implicated as the catalytic lysine.
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two different types of intersubunit contact (fig 7). The 1,2 intersubunit contact
is the major contact region involving both domains A and C. There is
considerably less contact in the 1,3 intersubunit contact region which involves
only the C domain and specifically the two a-helices Ca1 and Cct2. In those
enzymes which are reported to be dimeric, it would seem reasonable to
speculate that dimerisation occurred across this considerably less extensive
interface.
From the point of view of this project which involves an investigation into
the allosteric nature of pyruvate kinase, it would be a great advantage if the
structure of one of the allosteric forms of the enzyme were available.
However, studies of this nature have been hampered by the inability to grow
suitable crystals of any of the allosteric forms of the enzyme. Reports have
centred on the pyruvate kinase from the yeast Saccharomyces carisbergensis, a
close relative of Saccharomyces cerevisiae however the crystals obtained from
this source have not been found to be suitable for X-ray analysis (Hess and
Sosskina, 1978). The pyruvate kinase from Saccharomyces cerevisiae is 65%
identical, at the amino acid level, to the cat muscle enzyme, thus they may be
assumed to be structurally homologous. A model of the 3D structure of the
yeast enzyme was generated by Mr. T.H.L. Murcott, Department of Biochemistry,
University of Bristol, by superimposing the the yeast primary structure on to
the cat muscle co-ordinates using the Evans and Sutherland graphics facility
and the computer package FRODO. Access to this model was generously
provided by Dr. H. Muirhead and Mr. Murcott, which proved to be invaluable in
these studies. This model represents the structure of the yeast pyruvate kinase
in the T-state. The approach adopted in this project, to purify pyruvate kinase
from an overexpressing strain of yeast should yield yeast pyruvate kinase in
higher quantity than previously available. The enzyme can also be obtained
with a higher specific activity than was previously possible. Both of these
17
4 1.3
Figure 7; Tetramer of pyruvte kinase illustrating the two different types of
intersubunit interface.
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factors may yield better crystals of the enzyme, which will hopefully be suitable
for diffraction studies.
Attempts to make site-directed mutants of pyruvate kinase without the aid
of this structural model have been reported (Imarai, et a/, 1985). The authors
do not report how they chose which residues to mutate however it is known
that they had no access to the structural models described here. The residues
mutated were presumably chosen on the basis of their effect on catalysis after
reaction of the protein with chemically modifying reagents, however this is not
always a good way to identify residues directly involved in catalysis as many
residues which react with such reagents are simply surface accessible and
located at or near the substrate or effector binding sites. The mutations
K337Q, L and R, which involved changing the wild type lysine at postion 337 to
a glutamine, a leucine and an arginine residue were synthesised and expressed
in an attempt to attest the role of this lysine residue as being essential to
catalysis. Crude extracts are reported to show that mutants have similar levels
of activity to wild type controls, thus demonstrating that this is not the
essential catalytic residue. Examination of the structural model reveals that
this residue is not located at the active site of the protein, but in the substrate
binding site. Thus, this model proved invaluable for the design of mutations in
so far as it permitted the identification of residues more likely to be involved in
catalysis and regulation of the enzyme.
1.1.5. Comparison of allosteric and non-allosteric forms of pyruvate
kinase
It has recently been shown that the allosterically regulated mammalian M2
isoenzyme is encoded by the same structural gene as the Ml isoenzyme which
displays hyperbolic kinetics under physiological conditions (Noguchi et <?/,
1986). This gene contains 12 exons with two slightly different copies of exon 9
19
(fig 8). The gene is differentially spliced in a tissue specific manner which
remains poorly characterised. Exon 9 encodes a stretch of 54 amino acids of
which 33 remain identical between the two copies of exon 9, these translate to
give two a-helices designated Ca1 and Ca2 as they reside in the C-domain of
the protein. X-ray crystallographic studies reveal that these helices come
together to form the 1,3 intersubunit interface of the protein. Differential
splicing has been catagorised into 8 different classes (Breitbart et a/, 1987).
The pyruvate kinase system is an example of class 2, exon swapping. This is
reported to be very common in myosal cells and has hitherto only been
observed for the genes for the contractile proteins such as tropomyosin.
As the isoenzymes differ only in the region of this intersubunit contact it
seems reasonable to speculate that this is the region of the protein responsible
for conferring the allosteric properties of the enzyme.
1.1.6. The structure of yeast pyruvate kinase
So far, attempts at determining the crystal structure of the pyruvate kinase
from yeast have failed, as discussed in section 1.1.4. Pyruvate kinase is a
highly conserved protein, the yeast enzyme being 65% identical to mammalian
forms at the amino acid level. The three dimensional structures are generally
considered to be similar and the evidence for this is borne out by the fact that
it is reasonably easy to model the primary structure of the yeast enzyme using
the cat Ml isoenzyme structural coordinates, the dimensions and positions of
the major elements of secondary structure are well conserved between these
two forms of the enzyme. The only region where the yeast enzyme is
observed to be grossly different in structure to the cat M1 form is at the
N-terminus. N-termini tend to be the least conserved areas of protein
structure. The yeast N-terminus is much shorter than that of the cat Ml
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Primary transcript
8 poly (A) poly (A)
M^K mRNA M-PK mRNA
Fig. 8. Schematic representation of expression of the pyr¬
uvate kinase M gene. The Mx exon is indicated by the hatched box
and the M2 exon by the closed box. The exons common to both
mRNAs are shown by open boxes. TATA, TATA box; AATAAA,
poiyadenyiation signal; MLPK, Mr type pyruvate kinase; M2PK, M2-
type pyruvate kinase.
Figure 8; Diagrammatic representation of exon shuffling. Noguchi et at.
(1986).
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isoenzyme and this truncation would appear to take the form of a missing loop
(fig 3a,b). It would be interesting to examine the role of the N-terminus in
catalysis and in the regulation of pyruvate kinase. This region of the protein is
strongly implicated in the control of enzyme activity since it harbours the
serine residue which, in the liver isoenzyme, is phosphorylated under the
control of cAMP-dependant protein kinase. This phosphorylation radically alters
the catalytic properties of the enzyme as previously reported in section 1.1.3.
1.1.7. The advantages of studying yeast pyruvate kinase
The pyruvate kinase from Saccharomyces cerevisiae has been chosen for
these studies for a number of reasons. Firstly, it was anticipated that
overexpression of the enzyme in a homologous system would be
straightforward and could be achieved simply by transforming the host strain
with a multicopy plasmid vector bearing the structural gene. Genetic
manipulation of Saccharomyces cerevisiae is now almost as straightforward as
that in Eco/i and it is possible to disrupt and delete genes to alter the
phenotypes and genotypes of host strains so that they are tailored to
experimental requirements (Lundblad, 1989). A number of glycolytic enzymes
were already known to be overexpressed in S.cerevisiae, the most noteworthy
of these being phosphoglycerate kinase (PGK) (Wilson et a!, 1986) which, when
introduced into the yeast in a multicopy shuttle vector, produces around 80%
of the total cell protein as PGK thus making its subsequent purification and
kinetic analysis much more straightforward than from a non-overexpressing
strain.
1.1.8^The cataIytic activity of yeast _pyruvate kinase
The enzyme pyruvate kinase can catalyse a number of different reactions in
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addition to that described in the opening section. These include a fluorokinase
reaction in which ATP is used to convert fluoride into phosphofluoride using
bicarbonate, magnesium and potassium (Teitz and Ochoa, 1958), a
hydroxylamine kinase reaction whereby ATP is used to convert hydroxylamine
to phosphoamine using the same effectors as above (Kupiecki and Coon, 1959),
a glycolate phosphorylase reaction (Kayne, 1974) and an oxaloacetate
decarboxylase reaction (Noce and Utter, 1975). While it must be noted that the
substrate specificity of the enzyme is very variable, these reactions were all
examined in vitro and are not likely to be physiological.
The reaction catalysed by pyruvate kinase is essentially an acid base
reaction which occurs in two stages, the first being the transfer of the phospho
group of PEP to MgADP to yield an enolate intermediate and the second being
the stereo- specific protonation of this intermediate to give pyruvate (Rose,
1960). Phosphotransfer is known to take place by two different mechanisms:
1. DISSOCIATIVE The leaving group is eliminated to yield an unstable
metaphosphate intermediate followed by the rapid addition of the nucleophile.
2. ASSOCIATIVE The nucleophile is added first such that a pentacovalent
intermediate is formed followed by the elimination of the leaving group.
The reaction mechanism of pyruvate kinase has been extensively studied
and is considered to proceed by an in line associative mechanism with
nucleophillic attack on the phosphate to generate a trigonal bipyramidal
intermediate and subsequent inversion of configuration (Mildvan et at, 1976,
Hassett et a!, 1982).
The catalytic base in this reaction is considered to be the side chain of
lysine 269 which lies very close to the site of phospho-transfer. The evidence
from this comes both from crystallography and from the study of the pH
23
profiles of the enzyme. A group with a pK of 8.3 has been found to be the
acid-base catalyst implicating either a lysine or a histidine residue. (Dougherty
and Cleiland, 1985) The only such residue within a van der Waals distance of
PEP is lysine 269 (Muirhead et a!T 1987). Crystallographic evidence also
suggests that the side chain of this lysine may move when
phosphoenolpyruvate binds to the enzyme (Clayden, 1988). The most recent
line of evidence for an active site lysine comes from Electron Spin Echo
Envelope Modulation studies of the enzyme with V02+ ( Tipton et at, 1989).
These workers suggest that the catalytic lysine acts as the catalytic base to
mediate proton transfer from the solvent to phosphoenolpyruvate.
Pyruvate kinase requires a second magnesium ion in addition to that
complexed with the nucleotide, ADP. Magnesium can be substituted by
manganese and chromium, manganese being identified as a preferential
activator of the enzyme although magnesium is the ion observed in vivo
(Kayne, 1973). A number of independent lines of evidence exist to demonstrate
that a unique binding site exists on the enzyme for this magnesium ion (Gupta
■9
■•=* et at, 1976), Baek and Nowak, 1982). The role of the magnesium ion has
recently been ascribed as coordinating the phosphoryl group as it is transferred
from phosphoenolpyruvate to MgAOP during catalytic turnover (Tipton et aU
1989). This ion is also reported to be a ligand for the enolate leaving group.
The enolate is considered to be a very poor leaving group in the absence of
the enzyme bound magnesium .
The essential potassium ion has also been studied by NMR spectroscopy.
This ion can be substituted by a number of other monovalent cations, the
maximal activity of the enzyme with K* being a function of the ionic radius of
the cation (Villafranca and Raushel, 1982). The potassium ion is thought to play
a role in increasing the specificity of the enzyme for phosphoenolpyruvate by
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increasing the enzyme affinity for phosphoenolpyruvate and decreasing the
affinity for analogues and potential substrates where the carboxyl group is
missing (Nowak and Mildvan, 1972).
The nucleotide bound magnesium serves to reduce the electrostatic
repulsion between the phosphodonor, phophoenolpyruvate, and the nucleophiie,
enolate. It also helps to position the a and 8 phospho groups in the active
site. The nucleotide bound magnesium also performs these functions in other
kinases, e.g. phosphoglycerate kinase (Blake and Rice, 1981)
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\Z. A/B BARREL ENZYMES
Pyruvate kinase is one of the class of 17 known ct/8 barrel enzymes. These
are enzymes which contain an eight stranded a/8 barrel element of protein
tertiary structure (Richardson, 1981). The secondary structure consists of eight
8 strands alternating with one or sometimes two a helices. The chain folds so
that the eight strands form a parallel 8 sheet which twists to give a closed
barrel structure. The helices then pack onto the exterior of the barrel. Figure 9
shows the barrel structure of pyruvate kinase while Table 3 lists all known
enzymes with this element of tertiary structure and also describes some of the
common features that these enzymes share. In pyruvate kinase the element
comprises only one domain of a protein monomer, domain A. In this enzyme
the barrel is not a contiguous structure in that the main chain forms the first
part of the barrel then folds domain 8 before returning to complete the closed
barrel element. In the enzyme triosephosphate isomerase the barrel is
r
contiguous and forms the single domain of the protein monomer.
The active sites of most of the enzymes in table 3 are in the same position
with respect to the barrel, that is, in a cleft formed where the C-termini of the
8 strands folds around to join the N-termini of the a helices (Chothia, 1988).
The only exception to this would seem to be the rabbit muscle
fructose- 1,6-bisphosphate aldolase where the active site is located at the core
of the barrel, a region which is uncharged in all other enzymes of this class
(Sygusch et a!, 1987, Gamblin et aL 1990) Presumably the
fructose-1,6-bisphosphate aldolase has evolved a charged barrel core to bind
the highly negatively charged substrates of the reaction. Yeast enolase, while
first reported to be a member of this class of enzyme (Lebioda and Stec, 1988)
is now considered to have an S8aa<8a6) structure, that is to say that the 8
strands are not all parallel, one is oriented antiparallel to the others while one
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Figure 9; The a/8 barrel of pyruvate kinase.
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of the a helices is also reversed (Lebioda and Stec, 1989), However the
structure would seem to be sufficiently similar to merit its inclusion in this list
of enzymes.
The eight stranded barrel is a very interesting structure from an
evolutionary standpoint and contention rages in the literature as to whether the
structural element arose by a process of convergent evolution to a particularly
stable element, or by divergent evolution from a common ancestor (Levine et
aU 1978, Lebioda et aU 1982, Chothia, 1988, Lebioda and Stec, 1988). There are
three main lines of evidence which can suggest that enzymes have arisen from
a common ancestor, these are sequence similarities, structural similarities and
geometry of the active sites (Chothia, 1988). There is no doubt that these
enzymes are strongly structurally similar and in most cases the active site
geometries are identical, however there is no identifiable sequence similarity
between any of the a/8 barrel enzymes (Fothergill-Gilmore, 1986).
There is also a mathematical formula reported to determine the evolutionary
relatedness of any two structurally similar enzymes, derived from empirical
observations.
A = 0.40e187H
where A is the rms deviation of main chain atoms when the two similar
structures are superimposed, and H is the proportion of non-identical amino
acid residues (Chothia and Lesk, 1986). Since both of these criteria are readily
measurable, it is possible to feed them into the equation and, if both sides of
the equation are equal then the proteins can be said to have evolved from a
common ancestor. It would be very interesting to examine the relatedness of
the glycolytic enzymes with this structural motif. The fact that there are four
glycolytic enzymes with this common fold may be indicative of divergent
evolution from a common ancestor. This may not be surprising in the case of
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enolase and pyruvate kinase which catalyse sequential reactions in the
glycolytic pathway. Further evidence for the fact that they have evolved
divergently comes from the fact that they both require both a monovalent and
a divalent cation for full enzyme activity.
Recently an a/8 barrel protein has been synthesised de novo (Goraj et al,
1990). This was done by assuming that the structure was an 8 fold repeat of
four elementary structural features, a turn, a 8 strand, another turn followed by
an a helix. Plasmids were manufactured so that they could produce 7, 8, or 9
of these elements in tandem, in an £. coli cell. These proteins were referred to
as heptarellin, octarellin and nonarellin. Urea gradient gel electrophoresis
studies suggest that only octarellin can refold into a compact structure after
denaturation. This refolding is reported to be a. cooperative two state
transition. It is tempting to use this in vitro analysis as weight to an argument
t '
for convergent evolution to a stable folded structure. Further folding studies
on the a/8 barrels have been published recently, which demonstrate the
stability of the eight stranded barrel (Luger et at, 1990). The case for
convergent evolution is more difficult to argue as there can be no ancestral
evidence, as in the case for divergence. It has been suggested that, due to
constraints governing protein folding, proteins may only be able to adopt a
finite number of conformations. These constraints are thermodynamic and
kinetic and are determined largely by the primary structure of a protein
(Finklestein and Ptitskyn, 1987). In that case the eight stranded a/8 barrel may
simply represent the most stably folded structure for these proteins. Further
evidence for convergent evolution comes from the recent discovery that these
enzymes may be divided into two subtypes depending on the packing of the
interior of the sheet (Lesk et al, 1989). These two classes of enzyme could not
interconvert without gross rearrangement of the active site, and since one of
the shared properties of all but one of these enzymes is the position of the
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active site it seems unlikely that these have emerged divergently unless it was
from two different ancestral molecules. The most compelling evidence for
convergent evolution is the total lack of any sequence similarity between the
enzymes which share this structural element, however it is argued that this is
because divergence occurred so long ago that it is no longer observable
(Fothergill-Gilmore, 1986). It is generally accepted that bifunctional enzymes
arise from a gene duplication event, both parts of the enzyme then evolving to
catalyse its specific reaction. In the case of N-(5'phosphoribosyl) anthranylate
isomerase/indole-3-glycerolphosphate synthase, the separate domains have
only 10% sequence identity demonstrating that sequence identity is rapidly lost
during the evolutionary process (Preistle et aK 1987).
The most recent review on the evolution of the a/8 barrel proteins (Faber
and Petsko, 1990) suggests that these enzymes have diverged from a common
ancestor. The authors state that all of the 17 known a/8 barrel proteins are
enzymes. While this in indeed true, some of the enzymes have other biological
functions. Enolase is also found as a crystallin in reptile eye lens (Wistowge &
Pitigorsky, 1987) and monomeric pyruvate kinase is also reported to be a
cytosolic thyroid hormone binding protein in humans (Kato et al„ 1989). It is
not therefore strictly true to say that all of the proteins with the eight stranded
a/8 barrel motif have a catalytic function. In this review, a strong case for
divergent evolution is implied from the fact that all of the active sites are
located at the C-terminal portion of the barrel. While this is indeed true,
almost all of the substrates for these enzymes are highly negatively charged,
and binding to this face of the barrel is favoured by the helix dipole and the
charge distribution across the barrel. The authors then proceed to divide the
enzymes up into four broad structural families on the basis of the
crystallographic data, although they acknowledge that these crude structural
divisions are not conclusive proof of a common ancestor.
33
It is tempting to speculate that a/Q barrel enzymes first evolved to contain
a prosthetic group to facilitate catalysis such as flavin and 4Fe/4S in the case
of the trimethylamine dehydrogenase of the methylotrophic bacterium W3A (Lim
et aU 1986), then evolved to be able to undergo catalysis without the
prosthetic group. All of these enzymes catalyse reactions with planar
substrates, perhaps a reflection of the primordial cofactor. In this scenario the
most highly evolved enzymes would be those which catalysed a reaction with a
substrate which was not perfectly planar. Clearly it is impossible to do
anything but speculate on whether the eight stranded a/8 barrel emerged by a
process of convergent or divergent evolution. As new structures are
elucidated, perhaps new evidence may emerge. An interesting insight may be
gained by close studies of the archaebacterial counterparts of these 17
structurally solved proteins. Crystal structures of a few of these ancestral
proteins might give evidence of how the structures evolved.
1.3. SITE DIRECTED MUTAGENESIS
Site directed mutagenesis (SDM) is a reasonably new technology, initial
protocols for the technique being published as recently as 1982 (Zoller and
Smith, 1982). Initial experimental approaches involved the use of the
bacteriophage M13 (Messing et a/, 1977) as a source of single stranded DNA
template to which a mismatch oligonucleotide was hybridised and a second
strand synthesised in vitro using the mutagenic oligonucleotide as a primer.
This hybrid was then used directly for transformation of £ coli and the progeny
plaques screened by differential hybridisation with the mutagenic
oligonucleotide. In theory this method of SDM should be around 50% efficient,
in practise however, a much higher background of wild-type phage are
obtained and efficiencies of 1 - 3% are more commonly obtained. Within only
four years of the publication of these initial methods the technology has
improved such that efficiencies of 80 - 100% are routinely obtained. This
precludes the requirement for extensive screening since a few phage plaques
can be isolated and grown for DNA sequencing directly, without any primary
screening. Other advances in this methodology make it possible to replace any
amino acid, in a site specific manner, with each of the 19 others in only a few
steps, either by cassette mutagenesis (Wells et a/. 1985), or by using nonsense
surpressing tRNAs (Rossi and Zoller, 1987). Site directed mutagenesis need not
only be used to specifically change one amino acid residue. Oligonucleotides
may also be used to generate insertions or deletions in a DNA strand and a
single oligonucleotide can be deigned to alter any number of amino acid at any
one time. The applications of SDM are only as limited as the researchers
imagination. The value in relation to the understanding of the reaction
mechanism of pyruvate kinase and its regulation by allosteric effectors will be
discussed in this thesis. SDM is also used as a tool for the study of the
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mechanism of protein folding (Ackers and Smith, 1985), the understanding of
protein stability (Wells, 1987), the production of specialised translation systems
(Hui and de Boer, 1987) and protein/protein recognition (Staton et a/, 1988) to
cite only a few of the many examples.
1.3.1. SDM METHODS
The two methods of SDM most widely used are those of Kunkel (1985) and
Eckstein (1985), both of these methods are in use in our laboratory and are
highly efficient. The Eckstein method is supplied in kit form and relies on the
use of a synthetic dCTP analogue, dCTPaS, which makes the method fairly
costly since this analogue is not widely available. dCTPaS is incorporated into
a DNA duplex using an M13 single strand template and a mutagenic
oligonucleotide as a primer for second strand synthesis. This duplex is no
longer a substrate for certain classes of restriction endonuclease such that
they no longer cut the DNA at the recognition site where the analogue is ,
present, but produce a nick in the parent DNA strand. This nicked duplex is
then used as a substrate for limited digestion with EXO III so that the
non-mutated area of the duplex is removed. The duplex is repaired in vitro
with DNA polymerase and T4 DNA ligase and transformed into wild-type E.coli
cells. This process yields around 95% mutant plaques according to the
manufacturers instructions.
The Kunke! method utilises a strain of E.coli with a duf.ung genotype ,
deficient in the enzymes dUTPase and uracil-N-glycosylase, thus there is an
increased intracellular pool of dUTP such that dUTP is incorporated. into the
DNA more frequently. The ung phenotype prevents this dUTP from being
excised from the DNA by the usual repair mechanisms. Phage DNA propagated
from such a strain, when transformed into afdut^.ung"' strain, will no longer
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form viable progeny. If single stranded DNA from these phage is used as a
template for SDM and a second strand is formed in vitro using a mismatch
oligonucleotide as a primer for second strand synthesis, then this heteroduplex
used to transform dut+, ung+ host cells, only the mutant strand will form viable
progeny thus increasing the efficiency of the mutagenesis. Figure 10 illustrates
the sequence of reactions in the Kunkel mutagenesis method, this was the
method employed throughout this project and in my hands this turned out to
be 80-100% efficient.
1.3.2. THE MUTAGENESIS REACTION
Both of the standard mutagenesis methods require that the gene to be
mutated should be in a single stranded form. This is usually achieved by
cloning the gene of interest into a filamentous phage vector such as Ml 3 (
Messing et ai, 1 976).
The disadvantage of this system is that, although in theory insertsin the
M13 vector can be of any size, in practise, large inserts (> 1Kb) are unstable,
as are stretches of DNA with extensive secondary structure (Zinder et a/, 1982).
Attempts to clone the entire pyruvate kinase coding gene into M13 proved
unsuccessful, so a small fragment of the coding region was cloned and
mutated. Extensive subcloning was then required to produce the entire coding
sequence of the gene in an S. cerevisiae/E. coli shuttle plasmid for expression
of the mutant proteins.
One of the principal requirements of SDM is accurate DNA sequence data,
since it is from this information that mutagenic oligonucleotides are designed.
The gene for pyruvate kinase from S.cerevisiae had been cloned and its DNA
sequence determined prior to the onset of this project (Burke et at„ 1983)
Unfortunately there were errors in this published sequence which cadsed
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Figure 10; The Kunkel method of site directed mutagenesis.
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considerable delay to this mutagenesis project. The errors were located within
the region of the gene encoding the Ca1 and Ca2 helices. Initial attempts to
make mutants in this region all failed as the oligonucleotides were designed to
match the wrong sequence and so did not bind to the DNA at the points
predicted. This region of the gene is highly GC rich and the sequencing errors
are presumed to be a result of GC stacking in the sequencing gel. The
methods employed to alleviate this problem will be discussed. The gene has
now been completely resequenced and these errors corrected. These were the
only errors found in the entire gene.
1.3.3. DESIGN OF OLIGONUCLEOTIDES
The technique of SDM relies on the priming of a mismatch oligonucleotide
to a specific site on a gene, which drives the mutagenesis reaction and is the
basis of the site specificity. It is necessary to invest some careful thought into
the design of these oligonucleotides. Mutagenic oligonucleotides tend to be
around 18-20 bases in length so as to form a stable hybrid with the single
stranded template, thus allowing priming from the 3' end of the oligonucleotide.
The mismatch should be located slightly toward the 5' end of the
oligonucleotide, this again encourages a more stable 3'priming site. Optimally
the oligonucleotide should be as GC rich as possible to increase the binding
strength, however this will be largely determined by the sequence of the DNA
around the oligonucleotide binding site. It is particularly useful to have a G or
C residue at each end of the oligonucleotide wherever possible. It is useful,
too, to run the sequence of the oligonucleotide through a sequence matching
programme, such as GAP in the UWGCG package to ensure that it has no
significant identity with the sequence of M13. If significant matching does
occur, this may direct a mutation within the M13 genome which, if deleterious,
may abolish phage replication.
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In these experiments oligonucleotides were designed bearing in mind the
codon bias observed in S. cerevisiae (Bennetzen and Hall, 1983). Once an
oligonucleotide has been designed its effectiveness can be ascertained by
using it as a primer in a DNA sequencing reaction. Generally oligonucleotides
which prime a good, clean &NA sequence will make good mutagenic
oligonucleotides.
Once a mutant has been made it is necessary to design a system to effect
its characterisation.
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1.4. OVEREXPRESSION OF PYRUVATE KINASE IN SACCHAROMYCES CEREVIS1AE
The pyruvate kinase gene [pykT) from Saccharomyces cerevisiae has been
cloned by complementation (Kawasaki and Fraenkel, 1982), and the DNA
sequence determined (Burke at at, 1983, McNally et at, 1989). The pykt gene
is known to complement the cdcl9 mutation in 5. cerevisiae, a cell division
cycle mutation. This means that in the absence of a viable pyruvate kinase
gene, the cells fail to divide. It is not clear what relationship exists between
pyruvate kinase expression and cell division. If the two are interrelated one
might anticipate some difficulty in engineering yeast cells to overexpress
pyruvate kinase.
In general, the transformation of a yeast gene into yeast using a multicopy
(2u based) plasmid vector, leads to the synthesis of high levels of the gene
product. This does not appear to be -true for pyruvate kinase when under the
control of its own promoter, for although newly transformed strains
overexpress pyruvate kinase approximately 12-fold, the level of overexpression
falls back to wild type levels during continued culture on selective media, or on
storage on selective plates at 4°C. This phenomenon has been observed in
other laboratories (Al Brown and Toby Murcott, personal communications). The
over-expressing strain grows more slowly than wild-type, the growth rate
increasing as the level of overexpression decreases, suggesting that
overexpression of pyruvate kinase is deleterious to the cell.
The pykt gene is subject to dosage compensation (Moore et at. 1990a.)
This effect is obsen/ed both at the level of transcription and translation. That
is to say that, at the transcriptional level, in the presence of multiple copies of
the pyk 1 gene the number of copies of mRNA produced from each gene is
reduced. At a translational level, excess copies of pykt mRNA are translated
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less efficiently than basal levels. This phenomenon has so far been restricted
to gene families encoding histone and ribosomal proteins (Osley and Hereford,
1981, Warner et a/, 1985). Defects in these genes' can also give
rise to cdc mutations.
The dosage compensation effect is not observed with any other glycolytic
genes, indeed phosphoglycerate kinase, when overexpressed can comprise
50-80% of the total cell protein under certain conditions (Mellor et aK 1985)
with no apparent deleterious effect on the cells. Attempts have been made to
overexpress all of the glycolytic genes homologously in S.cerevisiae (Schaff et
aL 1989). Increased levels of expression were obtained for all of the enzymes
tested. The overproduction of pyruvate kinase and phosphofructokinase was
coupled by having the genes pykl, pfkl and pfk2 present on the same
multicopy plasmid. An increase in the activities of both of these enzymes led
to a decrease in cell growth rate. There are no reports of such studies using
the pfk genes alone. It has recently been demonstrated that the translation of
pfk mRNA is severely inhibited in the presence of high pykl mRNA levels
suggesting that the dosage compensation effect operates in trans, (Moore et
a!.1990b)
Activities of several enzymes involved in carbohydrate metabolism have
been measured during the cell cycle of S.cerevisiae (van Doom et ai, 1988).
Pyruvate kinase levels are seen to increase markedly during the G2 phase of
the cycle demonstrating that the levels of pyruvate kinase expression are
subject to some form of regulation during cell division. This periodicity was
also observed with hexokinase and phosphofructokinase, although neither of
these alleles complement cdc mutations. The precise nature of this periodicity
has not yet been determined. This form of regulation may reflect the fact that,
as ATP utilising enzymes, these are considered to be the rate controlling steps
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for the glycolytic pathway, so their levels may be decreased in order to reduce
flux through glycolysis.
When the pykl gene is transformed into S.cerevisiae under the control of
the pgk promoter, one of the strongest yeast promoters known, the levels of
pyruvate kinase protein produced are very high, around 20% of the total cell
protein. These high levels of protein production are maintained throughout cell
culture and storage and would seem to be of little or no disadvantage to the
cells (this work and J.Mellor, personal communication.) From this evidence it
would appear that the upstream control elements mediate the level of
expression. Upstream secondary structure formation is reported to reduce the
levels of translation of pyk mRNA(Bettany et ah 1989) but this could not
account for the reduction in the concentration of mRNA observed after
prolonged growth or storage.
An upstream activating sequence and upstream repressible sequence have
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been identified upstream of the pyk1 gene (Nishazawa et ah 1989). These
sequences are reported to comprise a mechanism for carbon source dependant
regulation of pyruvate kinase. Such cis-activating regulatory factors, when
present in high copy number, may dilute out some factor, as yet
uncharacterised, which is required for transcriptional regulation. During periods
of prolonged growth or storage production of this factor may be permitted to
increase such that it can exert a measurable effect on the transcription of the
pykl gene.
The pgk promoter has recently been shown to bind the product of the rap
gene, and rap is reported to activate transcription(Chambers et ah 1989). The
rap binding site has been identified and is similar, though not identical to the
upstream activator sequence reported in the pykl upstream region (Nishazawa
et ah 1989). In this same publication there is also reported to be an upstream
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repressive sequence in pykl. Such an upstream repressible sequence is also
reported in the ribosomal protein genes, which are also subject to dosage
compensation. It is not clear whether is related to the dosage
compensation phenomenon. However it is clear that dilution of a repressor
protein by overproduction of the site to which it binds could not give rise to
the dosage compensation effect which manifests itself as a decrease in protein
production.
The products of the hexokinase reaction are reported to control the
synthesis of the glycolytic enzymes, among these is pyruvate kinase (Maitra
and Lobo, 1971), however it was not clear at the time of their publication
whether this arose at the level of transcription or translation. This mechanism
presumably plays little or no effect on the inability to overexpress pykl under
the control of its own promoter since this induction is common to all the
glycolytic enzyme genes.
In all of the experiments where pykl was expressed under the control of its
own promoter, a large upstream area of the gene was maintained in the
multicopy vector. This area was around 2Kb in size. The uppermost regulatory
element thus far reported is at -811 bp from the start codon of the gene.
Sequencing studies on this area of chromosome 1 from S.cerevisiae show that
all of the cyc3 gene and at least part of the fun 10 gens are present on this
fragment of DNA (Coleman et <?/, 1986). One should not discount the
possibility that the altered expression of pykl is some hitherto unexplained
consequence of the overexpression of cyc3 or funlQ
Since experimental evidence strongly suggests that it is the upstream
region of the pykl gene which is deleterious to cell growth and not the
presence of the pyruvate kinase protein itself, the following strategy for
overexpression was adopted. The pykl gene was obtained cloned into the
expression vector pMA91 (Mellor et a!, 1986) such that pyruvate kinase
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expression was under the control of the pgk promoter. This construct was
used as the source of enzyme in these studies.
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1.5. ALLOSTERIC INTERACTIONS OF PROTEINS
Pyruvate kinases are allosterically regulated with the exception of the
enzyme from skeletal muscle (Hall and Cottam, 1978). Allosteric regulation of
proteins is defined as the modulation of protein activity by the binding of a
molecule, which is not a substrate molecule at a site on the enzyme distinct
from the substrate binding site. The binding of the allosteric effector to an
enzyme may either increase or decrease its catalytic activity. The term
'allosteric' stems from the Greek 'alio' meaning other and 'stero' pertaining to
shape.
Pyruvate kinase is also cooperative with respect to its substrate
phosphoenol pyruvate. Cooperativity is the phenomenon by which binding of a
substrate molecule to the substrate binding site facilitates the binding of
further substrate molecules to the other subunits of the protein. Allostery and
cooperativity are quite closely linked in that proteins frequently exhibit both of
these phenomena. Some proteins are cooperative but not allosteric ie. lamprey
haemoglobin (Briehl, 1963) but by far the majority are both allosteric and
cooperative.
The term 'allosteric' was first coined in a report concerning cooperativity
and feedback inhibition of enzymes published1 by Monod, Changeux and
Jacob in 1963. The concept of allostery was then considered to be "the
second secret of life", the first being the discovery of DNA. This original work
prophesied that "more complete observations, once available, might justify the
conclusion that allosteric transitions frequently involve alterations in quaternary
structure." It is just such an alteration in quaternary structure which is
proposed to effect the allosteric regulation of pyruvate kinase, and has been
demonstrated in a large number of allosteric proteins.
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Two models for allosteric control have been proposed. The first, the
original by Monod, Wyman and Changeux suggest that allostery and
cooperativity may arise in proteins with two or more structures in equilibrium.
It predicts that such proteins are likely to be made up of numbers of subunits
symmetrically arranged and that an alteration in the arrangement of these
subunits or the bonds between them would occur during the allosteric
transition. The model proposed two distinct structures, R and T, R being the
relaxed and more active form of the enzyme and T being the tense less active
form constrained by strong bonds that would resist the tertiary structural
change required for effective substrate binding. In the R form such constraints
are relaxed. This model is frequently referred to as the symmetry or concerted
model for allosteric control and has the limitation that all substrates for the
protein at any one time would be in one state.
The later model for allosteric control proposed by Koshland, Nementhy and
Filmer in 1966 had no such symmetry restrictions. Each substrate is permitted
to change its tertiary structure on substrate binding,and thereby to affect the
chemical activities of its neighbour?^ This is frequently referred to as the
sequential model.
A much later model by Cooper and Dryden (1984) proposes allostery
without conformational change suggesting that changes in entropy upon
effector binding are sufficient to alter the activity of the protein.
1.5.1.H a em og lobin
Heamoglobin was the first allosteric protein for which detailed
stereochemical information was available since the X-ray structures of both the
R and the T state were the first available at high resolution (Perutz 1978). The
simplest example of all the haemoglobins is that of Lamprey (Briehl, 1963).
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This protein is not regulated by allosteric effectors but is cooperative with
respect to oxygen binding. The reaction with oxygen is based on a reversible
dissociation into subunits. In the absence of oxygen the protein exists as
dimers and tetramers with low oxygen affinity but in the presence of oxygen
these dissociate into monomers with high oxygen affinity (Hendrickson and
Love, 1971). While lamprey heamoglobin may not be an example of a truly
allosteric protein, merely a cooperative one, it is an example of how a
cooperative interaction can affect an intersubunit boundary.
Human haemoglobin however is allosterically regulated. The protein is a
tetramer of two A and two B chains. Each subunit contains one haem
prosthetic group. Like pyruvate kinase the protein can be considered to be a
dimer of dimers, having one extensive intersubunit interface and one which has
a smaller surface area and as such is regarded as more flexible. Haemoglobin is
t *
allosterically regulated by H+, C02 and' 2,3-bisphosphoglycerate. At low
concentrations of oxygen, dissociation of tetramers into dimers can occur, an
analogous situation to that found in the lamprey enzyme. However, at
physiological oxygen concentrations an equilibrium exists between the deoxy T
state of the protein, the tense form of the protein with low oxygen affinity and
the oxy R state, the relaxed form with high oxygen affinity. The R and T forms
differ in the arrangement of the subunits and in the tertiary structure within the
subunits. The allosteric transition involves rotation of one pair of subunits
relative to the other about the less extensive intersubunit interface. (Baldwin
and Chothia, 1979). The tertiary structure of each dimer also changes to
compensate for the quaternary structural changes. The allosteric effectors all
exert their effects by encouraging the formation of hydrogen bonds to
specifically stabilise the T state of the protein and thus encourage dissociation
of oxygen from the protein (Fermi and Perutz, 1981). This review also
describes a number of naturally occurring mutants of haemoglobin found in the
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human population, some with altered hydrogen bonding specificity, which have
facilitated the study of the allosteric transition in this protein.
1,5.2. Glycoqen Phosphorylase
Glycogen phosphorylase b is reported to have been the first allosteric
protein to be isolated and analysed in detail (Cori and Cori, 1936), indeed, long
before the allosteric theories of Monod and Koshland had been proposed. The
enzyme is regulated by both allosteric interactions and reversible
phosphorylation (Graves and Wang, 1972). Phosphorylase a is the
phosphorylated form and is the active form of the enzyme. Phosphorylase b is
dependant on AMP for activity, and this activity is inhibited by ATP and
glucose-6-phosphate, which are allosteric effectors. Phosphorylase i is a
dimer of two identical subunits in the absence of effectors. Activation by
phosphorylation or in the presence of AMP produces a change in the
oligomeric state of the enzyme such that it becomes largely tetrameric, these
tetramers having only 12-33% of the dimeric enzyme activity. These tetramers
may be dissociated by glycogen or oligosaccharides to yield fully active
dimers.(Huang and Graves, 1970) Phosphorylase a the phosphorylated active
form of the enzyme is allosterically regulated by glucose. The earliest
crystallographic information on glycogen phosphorylase came in 1974 with the
publication of the T state phosphorylase b in the presence of the weak,
activator glucose-6-phosphate (Johnson era/, 1974), this was quickly followed
by high resolution data on the T state of phosphorylase a in the presence of
the allosteric inhibitor, glucose. (Kavinsky et at, 1976). Ven/ recently the
structure of the R state of phosphorylase b has been determined (Barford and
Johnson, 1989). Comparison of this structure with the others already obtained
gave information on the nature of the allosteric transition in glycogen
phosphorylase.
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The allosteric transition involves small changes in tertiary structure in the
ligand binding sites and subunit interface regions and little change in the
remainder of the subunit. These are coupled with large changes in the
quaternary structure which involve rotation of the two subunits of the dimer
with respect to each other. The change in quaternary structure directly effects
the the allosteric effector site and the serine phosphate.
Glycogen phosphorylas-e is a complex enzyme in terms of its regulation and
its variable quaternary structure, however, these recent studies are an excellent
example of how allosteric effectors exert their affects at the intersubunit
interface.
1.5.3. Lactate Dehydroqenase
Lactate dehydrogenase from Bacillus stearothermophilus has been
extensively studied by site-directed mutagenesis. At cellular protein
concentrations this enzyme is known to be a dimer with poor substrate affinity.
These do not readily associate to form tetramers as this would bring together
four positively charged pockets within repulsive range. In the presence of the
allosteric effector, fructose 1,6 bisphosphate these charges are neutralised and
the dimers can associate to form the high activity, high affinity tetramer. Site
directed mutagenesis has been used to alter the charge in the substrate
binding pocket, this does not affect the binding of the effector, nor does it alter
the catalytic activity of the inactive dimer, but allows formation of the
tetrameric form of the enzyme ( Clarke et at, 1989). This does not, however,
mimic the activation induced by effector binding. The allosteric activation of
the enzyme by fructose 1,6 bisphosphate involves a tertiary structural change
as well as an alteration in the quaternary structure. (Matsuzawa et a!1988)
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1.5.4. Phosphofructokinase
The enzyme phosphofructokinase catalyses the phosphorylation of
fructose-6-phosphate to form fructose-1-6-bisphosphate. The enzyme is a
tetramer of four identical subunits. Phosphofructokinase is allosterically
activated by ADP and GDP and inhibited by phosphoenolpyruvate, the substrate
of the pyruvate kinase reaction. The allosteric mechanism of the enzyme has
been extensively studied, as crystals of both the R and the T states of the
enzyme are available (Shirakihara and Evans, 1988, Schirmer and Evans, 1990).
The allosteric transition again takes the form of a rotation of two halves of the
tetramer relative to each other (Schirmer and Evans, 1989).
In the R state of phosphofructokinase, parallel 8 strands of neighbouring
subunits are linked at the interface by hydrogen-bonded water molecules. In
the T state these water molecules are expelled and direct hydrogen bonds are
observed between the 8 sheets. The relative rotation of the subunits directly
affects the catalytic site of the enzyme which lies near the subunit interface.
There is an arrangement of the amino acid side chains within the active site of
the enzyme on transition to the R and the T- state such that the ionic
environment switches from cationic to anionic repelling the substrate
fructose-6-phosphate. ATP binding is also made less favourable after this
transition.
Phosphofructokinase is also cooperative with respect to the substrate
fructose-6-phosphate yet not with ATP. This can be explained by the fact that
fructose-6-phosphate binding affects the intersubunit interface which is
involved in the allosteric transition, while ATP binds within a subunit domain
and is not sensed at this interface. The situation may be analagous to that
observed in pyruvate kinase which is cooperative with respect to the substrate
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phosphoenolpyruvate but not ADP.
The allosteric control of phosphofructokinase has also been studied by site
directed mutagenesis (Lau and Fersht, 1987, Lau et aL 1987). One very
interesting result was obtained with the mutation El87A, a change from a
glutamate to an alanine at position 187. This caused the allosteric inhibitor
phosphoenolpyruvate to become an activator, with the
phosphoenolpyruvate-bound R-state having a Vmax only 40% of the wild type.
Recent structural studies have confirmed that El87 is one of the side chains
which is reoriented during the allosteric transition. In the R state this side
chain binds Mg2+ and K213. The mutation E187A alters the effector binding site
such that the allosteric equilibrium of the phosphoenolpyruvate complexed with
the enzyme is shifted to the R state, and alters the tertiary structure of the R
state such that the catalytic activity is reduced. Other mutations in and around
the effector site back up the model of the allosteric transition derived from the
crystallographic data.
1.5.5. Aspartate Carbamoyltransferase
The enzyme from Eschericia coti has been extensively studied. The enzyme
is composed of two catalytic trimers and three regulatory dimers. The
holoenzyme is readily separated into a catalytic and a regulatory portion by
treatment with mercurials or mild heat. When examined separately it can be
seen that the holoenzyme and the catalytic segment of the enzyme differ
kinetically in that the specific activity of the catalytic subunit is only 50% of
that of the holoenzyme, and the substrate saturation curves for the catalytic
portion of the enzyme are no longer sigmoid, indicating the loss of
cooperativity (Kantrowitz and Lipscomb, 1990). Substrates are known to bind to
the catalytic fragment while effectors have been shown to bind to the
/
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regulatory portion of the enzyme (Gerhart and Schachman, 1965). Aspartate
trancarbamoylase has been reported to be a model for the Monod concerted
allosteric transition (Kantrowitz and Lipscomb, 1990), however these authors
report that substrates and substrate analogues for the enzyme can induce the
allosteric transition from the T to the R state. The alterations to the quaternary
structure in the face of substrate binding has been studied by X-ray
crystallography (Herve, et aK (1985)). The allosteric transition in aspartate
trancarbamoylase has been likened to the functioning of a differential gear
(Perutz, M.F. (1989)). The transition, which involves a rotation of one catalytic
subunit to the other, has been quoted as being an example of a concerted
structural change, in terms of the original Monod theory of allosteric control
(Kantrowitz and Lipscomb, 1990) however aspartate transcarbamoylase may be
a special case since this transition is brought about by substrates in this case.
1.5.6. Allostery without conformational chariga.
The allosteric theories of Monod et ai and Koshland et at. cited at the
beginning of this section both require a degree of conformational change to
take place during the allosteric transition, whether this change be concerted or
sequential. However a recent theory suggests that allostery may occur without
conformational change (Cooper and Dryden, 1984). Here it is proposed that the
allosteric effect may come about as a result of an entropic effect rather than a
conformational one, or may occur in tandem with a conformational change.
This paper also reports that cooperativity is also an entropic effect. In all
reports of allosteric control of enzymes so far investigated, the allosteric
transition is associated with conformation change. This is not the case for the
met repressor. This protein has no enzymic activity. It is a DNA binding
protein which regulates the expression of the enzymes requires for methionine
biosynthesis. It does this by binding to specific operator sequences in the
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genome of £ co/i Although the protein will bind to DNA alone, the affinity for
its specific operator is increased by two orders of magnitude in the presence
of the corepressor molecule S-adenosyl methionine (SAM). Corepressors can
be regarded as somewhat analagous to allosteric effectors if one considers the
repressor protein to be an 'enzyme' and the DNA as its substrate. The
aporepressor crystal structure in the absence of SAM, the holorepressor in the
presence of SAM, and the cocrystal structure in the presence of SAM and DNA
have all been solved to a high resolution. (Rafferty et ai. (1989), Somers et at.
in press.). No significant change in tertiary or quaternary structure of the
protein has been observed upon corepressor binding. The SAM analogue
S-adenosyl homocysteine has been demonstrated to bind to the protein in
vitro, but does not exert a corepressor effect. These two molecules are
isosteric apart from a positive charge on the methyl group of SAM. It is
implied that the 'allosteric' effect of the corepressor interaction hinges around
the presence of this positive charge rather than any alteration of tertiary or
quaternary structure.
1.6. Conclusion
How might this information be applied to the known structure of pyruvate
kinase? Pyruvate kinase is a tetramer which, like phosphfructokinase and
glycogen phosphorylase, can be viewed as a dimer of dimers, the 1,3 intersub-
unit interface being much less extensive than the 1,2 intersubunit interface.
The 1,3 intersubunit interface in pyruvate kinase is strongly implicated in the
54
allosteric control of the enzyme from sequence comparisons of the
allosterically regulated M2 isoenzyme in mammals with the non-allosterically
regulated Ml isoenzyme. These two enzymes differ only in the sequence
around the 1,3 intersubunit interface. Attempts to crystallise" pyruvate kinase in
the T state have so far been unsuccessful. It is tempting to speculate, in the
light of the evidence from other proteins discussed above, that the allosteric
transition in pyruvate kinase involves rotation about the 1,3 intersubunit
interface, and that, in the M1 isoenzyme, this rotation is prevented by the
amino acid sequence changes.
The rationale of this project was to study the allosteric transition of
pyruvate kinase using the yeast enzyme as a model. The plan was to engineer
site specific mutants of the yeast enzyme, mutated within the 1,3 intersuunit





All chemicals were of highest grade available and purchased through Sigma,
Poole, Dorset with the following exceptions, Phophoenolpyruvate (PEP) and
glass beads for yest cell disruption from BDH. Growth media were supplied by
Difco Labs,. X-ray film and radiochemicals were supplied by Amersham
International with the exception of y32P-dATP which was supplied in crude
form from New England Nuclear. Rabbit muscle pyruvate kinase, used as
protein gel standard was supplied lyophilised by Sigma, Lactate dehydrogenase
was obtained from Boehringer Manneheim as a saturated ammonium sulphate
slurry. All restriction enzymes were obtained from BRL, as was agarose for gel
eletrophoresis. All organic solvents were of the highest grade available and
purchased from BDH either through the deprtment of Biochemistry when
ordered in bulk, or directly by our laboratory. Oligonucleotides were
synthesised by the Oswell DNA synthesis service at the Department of
*
chemistry, University of Edinburgh.
2.2. STRAINS AND PLASMIDS
2.2.1. £ co//strains
HB101 F-, hsdS20, recA13. ara14, proA2, lacY1, ga!K2, rpsL20, xy!5, mt/1,
supE44
TG1 K12, 5 (lac-pro, supE, thi-1, hsdD5/F'traD36, proA+B+, laclq, lacZ6M15)
BW313 HfrKL 16, Po/45, thi-1, dut-1, ung-1, supE44.
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2.2.2. S. cerevisiae strains
SF747 mat-a, !eu2, ura3, trpl, gal 10
5pyk9 mat-oi, !eu2, ura3, trpl, gallO, pyk1::ura3
2.2.3. Vectors and Clones
pK19 (Pridmore R.D. (1987))
pUC18,19 (Yanisch-Peron C. et.al. (1985))
pJDB207 (Beggs J.D. (1981)
M13mpl8,19 (Yanisch-Peron C. et.al. (1985))
pAYE434 (figll)
pMA91-pyk (figll) (Mellor et.al. (1987))
M13-abl (f ig12 )
M13-ab2 (figl2)
pPYK20 ( f igl2 )




The vector pJDB207, and clones M13-aP1, pPYKIE, pPYK2E, pPYK3HEand
pAYE434 were a kind gift from Dr. A.J.P. Brown,(Dept. of Microbiology.
University of Aberdeen.) The plasmid pMA91-pyk was generously provided by
Dr. Jane Mellor (Dept. of Biochemistry University of Oxford.) The £ co/i strain
BW313 was donated by Dr. J.M. Miles (Department of Biochemistry, University
of Glasgow.) pUC and Ml3 vectors were supplied by Gibco-BRL, Paisley,
Scotland.
2.3. METHODS
2.3.1. Growth of E. coli strains
(a) M9 minimal medium.
This medium was used for the growth and maintenance of the F' strains,



















igure 11; Ptasmid maps of the E.co/i plasmids employed throughout this
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This solution was autoclaved at 1 5lb/in2 for 15 min then stored at 4°C.
M9 minimal agar.
15g of purified agar was dissolved in 860ml of distilled water by boiling,
then autoclaved at 15lb/in2 for 15 mins. The following ingredients were
sterilised separately then added aseptically to the agar solution along with




When 8W313 were grown on this medium a supplement of 50ugm/ml uridine
was added to boost the intracellular dUTP pool.
(b) 2xTY medium other bacterial strains ie HB101 and all Ml 3 infected
■a




This is autoclaved at 15lb/in2 for 15 min To make a solid medium 15g/l purified
agar was added prior to autoclaving. TY top agar was used in the growth of
M13 phage, in this case agar was added to a concentration of 6g/l.
2.3.2. Growth and maintenance of Plasmid strains
All plasmids, with the exception of those derived from pK19, had ampicillin
resistance markers. These were maintained by growth in 2xTY supplemented
with 100yg/ml ampicillin (sodium salt). Those plasmids derived from pK19
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which carries the kanamycin resistance marker were grown in 2xTY
supplemented with 25ug/ml kanamycin sulphate. All strains were stored as
15% glycerol stocks. These were made by growing a 1ml culture of the strain
under selective conditions then spinning down the cells and resuspending in
250pi 2xTY + 15% glycerol. Samples were then stored at -20°C.
2.3.3. GROWTH AND MAINTENANCE OF Ml3 STRAINS
M13 bearing strains were propagated in TG1 from minimal medium to
ensure that the strain maintained the F plasmid. Phage bearing cells were
grown in 2xTY medium for 4-5 hours to minimise recombination between the
phage molecules. Recombinant phage strains were maintained as PEG
precipitated phage molecules in sterile 2xTY broth at 4°C where they were
stable for many months, or as DNA in an ethanol precipitate stored at -20°C
indefinately.
2.3.4. Preparation of plasmid DNA
Plasmid DNA was prepared on three scales depending upon the purpose for
which it was required. The plasmid preparation methods are exactly as
described in "Methods in Enzymology" vol. 152. Where CsCI purification was
required to yield a pure preparation for DNA cloning, a large scale preparation
usually from 500m!s of culture was resuspended in 10ml of 1.1g/ml CsCI with
200yg/ml ethidium bromide and centrifuged at 50,000 rpm for 36 hours in the
Ti70 rotor of a Beckman L8 ultracentrifuge. DNA bands were visualized under
long wave U.V. light then removed by puncturing the tube wall with a 1ml
syringe and wide bore needle. Plasmid bands were extracted with water
saturated butanol until no more pink colour could be seen in the upper phase.
DNA was precipitated by the addition of 2 vol SDW, 1/10 vol 7.5M
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NH4CH3COOH and 2 vol ice cold isopropanol. This was then incubated at
-20°C for 60 min and spun 10,000 r.p.m. for 15 min to pellet the DNA. The
pellet was washed carefully with 80% ethanol, dried under vacuum then
resuspended in TE buffer to a concentration of approximately lyg/yl.
2.4.1. Restriction En zyme Cleavage
All restriction enzyme cleavages were performed in KGB buffer ( McClelland
1987) as described in the paper. For those enzymes which did not perform
well in this system, ie. BstEII, the buffer supplied by the manufacturer was used.
All incubations were carried out at 37°C for at least Ihour except in the case of
BstEII which was incubated at 65°C. Digests were carried out in a total volume
of 20yl and 1-3yg DNA were digested at a time.
2.4.2. Purification of DNA fragments from agarose gels r
DNA fragments were separated by agarose gel electrophoresis using TBE as
the electrophoresis buffer.
TBE Buffer
After electrophoresis at 100V for 2-3 hours bands were visualized on a short
wave U.V. transilluminator for the minimum length of time to avoid damage to
the DNA. Bands were cut out of the gel using a sterile scalpel blade and
placed in a sterile dialysis bag with 0.5 ml 1x TBE buffer. Both -ends of the
dialysis bag were securely sealed, the bag immersed in an electrophoresis tank







per litre, pH 8.3
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and subjected to 100V for 2-3 hours until all of the DNA was seen to leave the
gel slice using long wave UV illumination. The direction of the current was
then reversed for 2 min to remove the DNA from the wall of the dialysis bag.
The dialysis bag was then opened and the buffer containing the DNA removed.
The solution was phenol extracted once to remove all residual agarose which
would inhibit subsequent ligations, then the DNA precipitated with 0.4 vol 5M
NH4CH3COOH and 2 vol isopropanol, spun for 30 min in a microcentrifuge,
washed with 80% ethanol and dried under vacuum. The DNA was then
resuspended in 10u' SDW.
2.4.3. Ligation of DNA fragments
Ligations were performed in a total volume of 20yl, the components of the
reaction mixture were as follows;
DNA in TE or H20 13ul
lOx ligase buffer 2yl
lOmM ATP 2yl
lmM DTT 2yl
T4 DNA ligase 1 unit
care was taken to ensure that the ratio of insert to vector in any ligation was
approximately 10:1. Ligations were incubated at 15°C overnight. ATP and DTT
stocks were filter sterilised and stored at -20°C.
10x Ligase Buffer comprised; 200mM Tris-HCl (pH7.4), 100mM MgCI2.
Ligation reactions were monitored by agarose gel electrophoresis wherever
possible.
2.4.4, Preparation of competent cells
Competent cells were prepared by a modification of the method of Mandel
and Higa (1970). 1ml of an overnight culture of cells was used to seed a 100ml
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flask of 2x TY broth. This flask was incubated at 37°C with vigorous shaking
until the culture reached O.D.600 = 0.3, this usually took 1.5-2 hours. Cells
were spun at 5000 r.p.m for 5 min then resuspended in 50ml 100mM CaCI2 in
the cold. From this point in the preparation every attempt was made to keep
the cells as close to 4°C as possible. The cells were incubated at 4°C for 1
hour then spun again as before. The pellet was taken up in 2mls ice cold
100mM CaCI2 and left overnight at 4°C to ensure a high level of competence.
Competent cells could be kept this way for up to a week after which time they
were no longer sufficiently efficient in the uptake of DNA to be of use.
2.4,5. Transformation of competent cells
Competent cells were transformed as follows;
300pl of cells were pipetted into a standard test-tube and placed on ice.
An aliquot of DNA was added in a volume no greater than 20containing
optimally 10-100ng of DNA, this was incubated on ice for 20 min to 1 hour
with occasional gentle mixing to allow adhesion of the DNA to the cell surface.
The cells were then heat shocked at 37°C for 5 min and replaced on ice. 1ml
of sterile 2xTY broth was added aseptically to each tube and the mixture
shaken at 37°C for 1 hour to allow expression of the antibiotic resistance.
Cells were then plated onto appropriate selective media and grown statically at
37°C overnight. This same basic protocol was used for the transformation of
M13 with the following modification; Cells were heat shocked as described
previously and replaced on ice, 200ul of an overnight culture of TG1 cells were
added to each tube along with 3mls of molten top agar pre-cooled to
45°C. This was mixed gently by rolling and poured onto the surface of a dry 2x
TY agar plate then incubated overnight as before to allow plaque formation.
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2.5. GROWTH ANO MAINTENANCE OF YEAST STRAINS
2.5.1. Media
Strains of the yeast Saccharomyces cerevisiae were grown on the rich




Where the yeast strain was harbouring a plasmid, a synthetic medium was
required to complement the nutritional marker on the plasmid. This comprised;
1.7g/l yeast nitrogen base (w/o amino acids)
5g/l (NH4)2S04
20g/l glucose
(for the pyk1::uralll disrupted strain dextrose is replaced by
20g/l pyruvate)
10ml of amino acid ommission stock.
Amino acids are added to the medium after autoclaving at 15 lb/in2 for 15 min.
Stock solutions of the amino acids are made up with particular amino acids














L-Tryptophan was autoclaved separately at a 100x stock concentration of 0.2%
w/v and stored in the dark at 4°C. Where leucine was required in the medium it
was added at a concentration of 60yg/ml. For growth of uracil was ommitted
from the medium to ensure selection for the disrupted allele.
All liquid media were made into solid plates by the addition of 2% pure
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agar. All yeast media were autoclaved at 15 lb/in for 15 min prior to use.
2.5.2. Plotting a growth curve
Growth rate experiments were performed on all strains. This was done
using synthetic media as described above. The strain pyklr.uralll was grown on
Yo + 2% pyruvate with leu, ura omission stock. Other strains were grown on
Yo medium + 2% dextrose with csnissions as required. 100ml cultures were
inoculated with cells of the appropriate strain and grown with vigorous shaking
at 30°C.. 1ml samples of culture were taken at recorded times and the O.D.c„-,ouu
recorded, this measure of the light scattering of the culture is proportional to
the cell density. The results were plotted on a graph of cell density versus
time to give a growth curve.
2.5.3. Determining optimal Pyruvate for growth
The optimal concentration of pyruvate for growth of the strain pykl::uralll
was measured by setting up a range of tubes of Yo minimal medium with
•si
varying concentrationd of pyruvate from 0-4% w/v. The pyruvate was added
aseptically from a filter sterilised 20% stock solution. The cells were grown at
30°C. with good aeration for 20-30 hours after which the O.D.8Q0 was measured
on 1ml samples from each tube to give a measure of the cell density.
2.5.4. TRANSFORMATION OF YEAST CELLS
Yeast cells were transformed by two methods, the Li CH3COOH
?
pretreatment method of Ito (1987), and the sphaeroplast transformation method
of Burgers (1988). Both of these methods work well. Although Li CH3COOH
was less laborious, it was necessary to include an overnight preincubation in
rich media to allow expression of the defective Ieu2~d allele present on both of
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the shuttle vectors used before plating onto selective media. Putative
transformants were tested for recovery of the transformed plasmid in an £ co/i
strain in a plasmid rescue experiment.
2.5.5. Plasmid Rescue from yeast transformants
1.5mls of overnight yeast culture was harvested by centrifugation, the
supernatant discarded and the process repeated two further times so that the
pellet from 4.5ml of overnight culture was eventually harvested. Cells were




25ui 10mg/ml lyticase was added and the tube mixed by inversion and
incubated at 30°C for 20-40 min until more than 90% of cells had formed
sphaeroplasts, as determined microscopically. Sphaeroplasts were harvested by
centrifugation at 6500 rpm in a microcentrifuge for 30 sec, then resuspended in
100yl 1 M sorbitol. Cells were lysed by the addition of 800ul of lysis buffer;
100mM Tris-HCl( pH 9.7)
50mM EDTA(pH 8.5)
0.5% SDS
and incubated at 70°C for 20 min, 200ul 5M KCH3COOH was added and the
mixture left on ice for 45 min. Cell debris was pelleted by a 10 sec. spin in the
microcentrifuge and the supernatant carefully decanted, 550yl of ice cold
isopropanol was added and the mixture left at room temperature for 5 min The
DN"A was pelleted by centrifugation for 15 min and the pellet washed with 70%
v/v ethanol and dried under vacuum then resuspended in 20ylTE buffer. 10yl




A gene disruption was performed on the yeast strain SF747. This allowed
the insertion of a ura3 marker into the pykl locus of the genome. This ensured
that the expression of mutant protein was not hindered by a background of
wild type contamination.
The gene disruption method used was that of Lee (1984). A bacterial clone
was synthesised from pPYK20 by linearising this plasmid with Bglll and ligating
in the yeast ura3 gene which was obtained on a BamHI fragment from Dr.
G. Reid, Dept. of Microbiology, University of Edinburgh. This construct was cut
with HinDIII to give an 8.9Kb fragment of DNA containing the entire pyk gene
with its upstream and downstream flanking sequences interrupted by the ura3
coding sequence. These linear DNA fragments were transformed into the yeast
cells by alkaline cation pretreatment as described previously The linear ends
have a 1000fold increased recombination efficiency and thus encouraged
chromosomal insertion of the ura3 gene into the pyk locus on chromosome 1
of the yeast genome. Transformants were selected by growth on Yo medium +
3% glycerol, 3% ethanol without uracil to select for complementation of the.
ura3 auxotrophy of the yeast strain pJDB207. These were then tested for the
ability to grow on glucose. Those where the gene was positioned in the pyk
locus could no longer undertake glycolysis and thus could no longer use
glucose as the sole carbon source. The method is summarised in figure15
Transformants took 14 days to appear on the glycerol/ethanol medium so
attempts were made to find a more efficient growth system. The best medium
seemed to be Yo + 2% pyruvate.
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2.5.7. Isolation of Yeast Chromosomal DNA
In order to characterise the disrupted strain further, a Southern blot of
yeast chromosomal DNA was prepared from disrupted and control strains, and
probed with both pyk1 and ura3 to illustrate the chromosomal insertion. High
molecular weight chromosomal DNA was extracted thus;
Cells from a 5mi culture grown to an A55Q of 5-10 were harvested by
centrifugation and resuspended in 500yl 1M sorbitol. 20yl of 10mg/ml lyticase
was added and the cells incubated at 30°C for 1 hour after which time the
sphaeroplasts were pelleted by spinning for 2 min at low speed in a
microcentrifuge. Sphaeroplasts were lysed by the addition of 50yl 10% w/v
SDS and the tube incubated at 65°C for 20 min 200yl 5M KCH3COOH was
added to precipitate the cell debris and the tube incubated on ice for 30 min
The debris was pelleted by centrifugation for 5 min in a microcentrifuge at
13000 rpm. The supernatant was decanted into a 1.5 ml Eppendorf tube and
absolute ethanol added to precipitate the DNA. DNA was pelleted in the
microcentrifuge by spinning at high speed for 5 min The pellet was vacuum
dried and resuspended in 300yl TE buffer. 50yl of 10mg/ml RNaseA was added
and the tube incubated for 1 hour at 37°C. 500yl of isopropanol was added to
reprecipitate the DNA. DNA was pelleted as before and then washed with 80%
ethanol and vacuum dried. This DNA is a suitable substrate for restriction
endonucleases.
2.6. SOUTHERN BLOTTING
Southern transfer was performed as a modification of the method devised by
Southern (1975). DNA was cut with the restriction enzyme HinDIII and run out
on a 0.7% agarose gel in TBE buffer until the bromophenol blue dye front
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reached the end of the agarose gel slab. The gel was stained with ethidium
bromide and photographed. The DNA was denatured in the gel prior to
Southern transfer by shaking for 30 min in a solution of 0.5M NaOH and 1.5M
NaCI. The gel was then neutralised by shaking for 1 hour with 1M Tris-HCl
pH8.0 and 1.5M NaCI with 3 changes of buffer. There should be enough
solution in each of these cases to cover the gel completely during the shaking
procedure. The gel was set up for Southern transfer as shown in the paper.
Transfer was judged to be complete when 1 litre of solution had transferred
through the gel. Hybond-N was used as the transfer matrix. This has the
advantage of being less brittle than nitrocellulose and need not be baked in a
vacuum oven to fix the DNA, indeed, DNA was fixed to the membrane by 2 min
exposure to UV light. The hybridisation method is described in section (2.7.7.)
2.7. SITE DIRECTED MUTAGENESIS
I
Site Directed Mutagenesis was performed by the method of Kunkel (1985)
with the following modifications:
The strain of £ co//BW313 was used as tbjs has no amber suppressor and
so is suitable for use with M13mp18 and 19. £ co/i strain TG1 was used as
the ung+ control.
2.7.1. Growth gf_Phage
A single plaque of M13ab1 was removed from a plate and placed in an
Eppendorf tube containing 1ml of TY broth. This was then vortexed thoroughly
and heated to 60°C for 5 min to kill all E.co/i cells. The tube was then spun for
2 min to pellet agar and cell debris. The supernatant was then used to
inoculate a flask containing 100ml of TY broth + 0.25ug/ml uridine to which
5mls of a log phase culture of 8W313 had been added. This was grown with
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good aeration for 18 hours.
2.7.2. Preparation of Phage
The culture centrifuged at 500xG for 30 min, the supernatant collected,
mixed with 0.4 vol. 20% PEG/2.5M NaCI and incubated at 4°C for 1 hour. Phage
were collected by centrifugation at 500xG for 30 min All of the PEG/NaCI mix
was carefully removed with a drawn out Pasteur pipette then the pellet
resuspended in 1ml TE in an eppendorf. This was then spun for 30 min at
13000 rpm in a microcentrifuge to remove all possible remaining cell debris
then reprecipitated with PEG/NaC! as before. This final phage pellet was
deemed sufficiently pure to continue with extraction of the phage DNA. A
small sample of these pure phage were used to titrate ung" and ung" cell lines.
If there was less than 10,000 fold drop in ung" survival the DNA was not used
for mutagenesis.
2.7.3. Preparation of DNA
The phage pellet was resuspended in 500ul of TE then phenol extracted 3x
using a phenol solution equilibrated to pH8.0 with 0.5M Tris-HCI. The top layer
was then extracted 2X with diethyl ether. The lower phase from the final
extraction was then extracted with 24:1 chloroform:isoamyl alcohol. The final
extract was divided into two Eppendorf tubes and mixed with 625pl absolute
ethanol and 25pl 3M Na CH3COOH to precipitate the DNA. DNA was pelleted
by spinning 15 min in a microcentrifuge at 4°C. This pellet was then washed
with 1ml of 80% ethanol and dried under vacuum until there was no residual
alcohol. The DNA pellet was taken up in TE to a concentration of 1 pg per ml
as determined by A26Q. This preparation yields approximately 150 pg of DNA.
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2.7.4. 3'-phosphorylation of oligonucleotides.
2.5ul oligonucleotide (5 OD units/ml stock from Oswell)
3.0 Ul 10x kinase buffer (1M Tris-HCl pH 8.0, lOOmM MgCl2, 70mM
dithiothreitol, lOmW ATP)
25 Ul SDW
2u T4 polynucleotide kinase
This mixture was incubated at 37°C to allow the end labelling reaction to
occur then heated to 70°C to destroy the enzyme. The oligonucleotide was
either used straight away or stored at -20°C prior to use.
2.7.5. Mutagenesis Reaction
The phosphorylated oligonuleotide was annealed to the single stranded DNA
template as follows:
1 pi of template DNA
1 ul phosphorylated oligonucleotide
1 ul 10X Klenow reaction buffer
7 ul SDW
Klenow reaction buffer comprised 100mM Tris-HCl pH8.0, 50mMMgCI2 This
mixture was heated to 65°C for 5 min then allowed to cool slowly in a beaker
of water until .the temperature dropped below 25°C. 1pl Klenow DNA
polymerase (10 units) and 1 ul T4 DNA ligase (1 Weiss unit) were added and the
tube incubated at 15°C for 18 hours. A 1 ul sample was taken at this stage to
assess the efficiency of the polymerisation reaction. Single stranded DNA runs
distinct from double stranded on a 1% agarose gel. 1 ul and 5ul samples were
then transformed into competent TG1 cells and incubated O/N at
37°C. Samples of the resulting plaques were picked and grown in 1.5mls TY
broth seeded with 10ul of a log phase culture of TG1. In initial experiments 10
plaques were picked at a time and subjected to T tracking (as described in
section 2.8.5.) to assess the efficiency of the mutagenesis reaction. Once it
was demonstrated that the efficiency was around 80% ie out of any 10 plaques
chosen at least 8 would be mutant, then 4 plaques were selected and
sequenced fully using the Sequenase kit. In all cases at least 3 plaques out of
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the four selected were seen to be mutants. A flow diagram of the Kunkel
mutagenesis method is shown in figure 10
The mutant K269R was difficult to screen by sequencing alone since the
site of the mutation was greater than 200bp from the sequencing primer and
the sequence change from CAGAAT to CAAGAT was difficult to detect even on
long run sequencing gels, so this mutant was screened using a radioactive
labelled oligonucleotide then later sequenced to verify the mutation.
2.7.5. La belling of the oliqonuc I eotide
10X kinase buffer (as before)
3yl y-32p dATP
lunit T4 polynucleotide kinase
lpl oligonucleotide (5 OD units/Ul)
18yl SOW
incubated at 37°C for 1 hour.
T
2.7.6. Preparation of Filter
DNA prepared from putative mutant plaques was arranged on a Hybond-N
filter using a Schleicher and Schuell slotborting apparatus. Filters were
prepared using the manufacturer's instructions. 5pl of each DNA clone was
applied to individual wells of the apperatus. DNA was fixed to the filter by
irradiation with UV light for 5 min. Filters were stored dry, wrapped in clingfilm
prior to hybridisation.
2.7.7. Prehybridisation/Hybridisation







The filter was prehybridised in 10ml of this solution, in a sterile petri dish, at
room temperature for 1-3 hours then, after addition of the labelled probe, was
hybridised for a further 18 hours. The filter was then washed at sequentially
increasing stringencies to differentially remove the probe from the negative
controls and reveal positive clones.
2.8. DNA SEQUENCING
DNA sequencing was performed by the chain termination method of Sanger
(1977) using both Klenow DNA polymerase and latterly Sequenaser.
2.3.1. KLENOW SEQUENCING
Klenow DNA sequencing was performed as described in the Amersham M13
"Cloning and Sequencing Handbook.
2.8.2. Sequencinq reactions
1) 1 OX Klenow reaction buffenIM Tris-HCI,500mM MgCI2 2)
dNTP/ddNTP solutions
dCTP/ddCTP: 0.50mM ddCTP, 0.16mM dGTP, 0.16mM dTTP, 0.008mM dCTP
dTTP/ddTTP: 0.25mM ddTTP, 0.16mM dCTP, 0.16mM dGTP, 0.008mM dTTP
dGTP/ddGTP: 0.50mM ddGTP, 0.16mM dCTP, 0.16mM dTTP, 0.008mM dGTP
dATP/ddATP: 0.50mM ddATP, 0.16mM dCTP, 0.16mM dGTP, 0.160mM dTTP
3) Chase solution: O.SOmM dATP, 0.50mM dCTP, O.SOmM dGTP, O.SOOmM dTTP
4)Formamide dye mix:0.3%(w/v)xylene cyanol FF, 0.3% (w/v)bromophenol blue
20mM EDTA in SDW.)
2.8.2. Growth of phage
One plaque of an M13 clone was aseptically inoculated into 1.5ml of TY
broth seeded with lOyl of a log phase culture of TG1 and grown at 37°C with
good aeration for 5-6 hours.
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2.8.3. Preparation of template
The bacterial culture was spun in a microcentrifuge for 5 min to remove all
bacterial cells. Phage were precipitated from the supernatant by addition of
0.4vol. 20% w/v PEG/2.5M NaCI and incubated at room temperature for 15 min
The phage pellet was spun down for 10 min in a microcentrifuge and the
supernatant removed. The pellet was then spun again to bring down all the
residual PEG/NaC! and this was carefully removed from the pellet with a drawn
out Pasteur pippette. The phage pellet was then resuspended in 50ui TE and
phenol extracted to remove the protein coat, then chloroform extracted to
remove both residual phenol and PEG. DNA was precipitated by the addition of
1/10 vol 3M Na CH3COOH and 2 vol. ice cold absolute ethanol. This was
incubated at -20°C for 1 hour, spun for 30 min in a microcentrifuge then
vacuum dried to remove all traces of ethanol. This pure DNA was then
resuspended in 20pl of TE.
r
2.8.4, Annealing of primer to template
5pl of DNA template
lpl of 1/500 dilution of oligo
l|il of 10X Klenow reaction buffer
3]ll SDW)
Incubated at55°C for 1 hour .
P_o lymerisation
1 ul [a35S]-dATP and 1 unit Klenow DNA polymerase were added to the
annealed primer/template mixture. 2.5pi of this was placed in each of 4
Eppendorf tubes labelled A,C,G and T and placed in a microcentrifuge, 2yl of
each of the dNTP/ddNTP mixes were added to their respective Eppendorf tubes
and spun briefly to mix. The polymerisation reaction was allowed to continue
for 20 min at which time 2pl of chase mix was added to each tube. After a
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further 15 min incubation the reaction was stopped by the addition of 2pl of
formamide dye mix. The samples were then electrophoresed immediately or
stored at -20°C until required.
2,8.5. Selective Screeninq/T-Trackinq
4pi 1 sequencing primer
6pl 10X Klenow reaction buffer
12 pi SDW
Add 2pil of this mix to each of 10 Eppendorfs along with 2ui DNA template
and incubate at 60°C for 1 hour to anneal the primer and template. Meanwhile
mix 16ul dTTP/ddTTP mix with 2u' ct35S-dATP and 2 units Klenow DNA
polymerase. Add 2pl of this to each of the 10 Eppendorfs and incubate 20 min
at room temperature. Add 1pl of chase mix to each tube then incubate for a
further 15 min before adding 1pl of formamide dye mix to stop the reaction.
2.8.6. Gel Electrophoresis and Autoradiography
40 % w/v acrylamide stock.
38g acrylamide
2g NN'-me thylenebisacrylamide
distilled water to lOOmls
Add 5g amberlite resin, stir gently for 30 min then filter through sintered glass











Distilled water to 160ml,
Use straight away or store in the dark at 4°C. )
2.8.7. The sequencing gel
The BRL SO gel electrophoresis system was used. This gives a gel of
40x20x0.4cm The plates were washed thoroughly then rinsed in acetone and air
dried to remove all traces of detergent from the surfaces. Two spacers of
0.4mm thickness were laid along the edges of the plates. The gel plates were
then sealed together using BRL gel sealing tape to create the gel sandwich.
The gel mix was prepared in a beaker, 80mls of sequencing gel stock with 60u'
TEMED and 60pl freshly prepared 10% ammonium persulphate. The gel mix
was then carefully poured between the gel plates, holding the plates at an
angle of 30° to the lab bench and tapping the top surface of the sandwich to
remove any trapped air bubbles. Once all air bubbles were removed the gel
sandwich was laid horizontally on the lab bench and two sharks tooth combs
were inserted flat face down to give a smooth gel top. The gel was then
allowed to set for at least 30 rnin after which time the sealing tape was
removed and the gel clipped onto the running frame. Buffer ( IX TBE running
buffer) was added to both reserviors and the set-up checked for leaks. The
combs were then carefully removed and inverted to give the sample loading
wells. Sequencing samples were boiled for 3 min to denature the double
stranded DNA then stored on ice before loading onto the gel. The gel was run
at 60W constant power during which time the bromophenol blue and xylene
cyanol dye fronts separated. The final run length varied depending upon the
information required. A short run to the bromophenol blue dye front gave
sequence information from 3-4 bp 3' of the primer up to approx. 150 bp away.
Allowing the gel to run to the xylene cyanol dye front allowed approximately
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another 50-100 bp to be read from a single gel run.
Sequencing gels were fixed in 12% methanol/10% acetic acid (v/v) for 30
min to remove urea, then dried for 90 min at 80°C. Autoradiography was
performed using Amersham Hyperfilm in GRI film cassettes with intensifying
screens. The films were exposed for 18-24 hours at room temperature.
2.9.1. SEQUENASE SEQUENCING
The Sequenase sequencing reactions were carried out exactly as described





80UM dCTP, 80UM dTTP,'
80 |iM dCTP , 80 UM dTTP
5X Sequenase buffer; 200mM Tris-HCl pH 8.0, lOOmM MgCl2, 250mM NaCl
5X labelling mix; 7.5UM dGTP, 7.5UM dCTP, 7.5UM dTTP
dNTP/ddNTP solutions.
ddG; 80UM dGTP, 80UM dATP,
8UM ddGTP,50mM NaCl.
ddA; 80UM dGTP, 80UM dATP,
8UM ddATP, 50mM NaCl.
ddT; 80UM dGTP, 80UM dATP, 80UM dCTP, 80 UM dTTP
8UM ddTTP, 50mM NaCl.
ddC; 80UM dGTP, 80UM dATP, 80UM dCTP, 80UM dTTP
8UM ddCTP, 50mM NaCl.
Stop solution; 95% formamide, 20mM EDTA, 0.05% Bromophenol blue,
0.05% Xylene cyanolFF. )
2.9.3. Annealinq primer to template
Phage DNA was prepared as described above.
Primer lpl of 1/500 dilution of Oswel stock
Sequenase buffer 2pl
DNA template 7pl (approx 2ug)
Were placed in a capped Eppendorf and heated to 65°C for 2 min then allowed
to cool slowly to room temperature in a beaker of water prewarmed to 65°C.
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2.9.4. Polymerisation
Sequenase enzyme was diluted 1/8 in ice cold TE just prior to setting up the
react ion.
The following was added to the annealed primer/template mix;
0.1M DTT 10 pi
lx labelling mix lpl
a35S-dATP 0 . 5Vi 1
diluted enzyme 2]ll
This was mixed and incubated at room temperature for 5-10 minutes. Four
Eppendorfs were set up labelled A, T, C, and G and 2.5u' of ff>e respective
dNTP/ddNTP mix was added to each. These were prewarmed to 37°C for at
least 1 min before the addition of 3.5pl of reaction mix. Incubation was
continued at 37°C for at least 5 min although incubation of up to 30 min is
reported to have no effect on the sequencing reaction. Reactions were
stopped by the addition of 2pl of stop mix (deionised formamide, 0.1% xylene
cyanol, 0.1% bromophenol blue).
2.9 J5. Gel electrophoresis and autoradiography
This was performed exactly as described above. Longer runs are possible
with the Sequenase kit by using the 5X labelling mix undiluted in the
sequencing reaction and allowing the reactions to run for the maximum
recommended time (30 min) then it is possible to read 300-500 bp away from
the primer.
Problems were encountered with both of these methods when sequencing
the "corrected" area of the pyruvate kinase sequence. These are thought to be
caused by stacking of the GC base pairs since this is a particularly GC rich
area. Theseproblems were overcome by the use of 7-deaza dGTP in the
Klenow sequencing mixes in place of, and at the same concentration as dGTP.
This derivative of dGTP can form only two hydrogen bonds with dCTP and so
eliminates stacking problems. Substitution of the dGTP mixes of the
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Sequenase kit with dlTP as detailed in the manufacturers instructions did not
alleviate the base stacking difficulties.
2.10. Protein preparation
P re p a ra tion of CibacronBlue-Sepharose
CibacronBlue 3GA was purchased from Sigma(Poole, Dorset) Sepharose 68
was purchased from Pharmacia(Uppsala, Sweden) and was supplied preswolen
in 1 litre batches.
To couple the dye to the matrix 1g of the dye was added to lOOmls of the
Sepharose suspension and the mixture was brought to pH 11.0, then stirred
gently at room temperature overnight to catalyse the binding of the dye to the
gel. The gel was then washed extensively with distilled water until no more
blue dye could be eluted and poured into a column 16 x 3 cm and equilibrated
with 200 mis extraction buffer.
2.10.1. Protein extraction from yeast
(1) small scale
Small scale protein preparations were performed on yeast cuitures to
ascertain the degree of overexpression of pyruvate kinase. In these instances a
10mls yeast culture was harvested and concentrated into an Eppendorf tube.
The cells were resuspended in 100p! of protein extraction buffer (50mM MES,
3mM MgSO4,20% glycerol). 1 spatula tip of glass beads (40 mesh) was added
and the sample vortexed for 2 min then cooled on ice for 2 min before
spinning in a microfuge to remove all cell debris. The supernatant was
removed and an equal volume of boiling mix added, the sample was then
boiled for 5 min prior to SDS-PAGE.
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(2)Large (preparative) scale







1 litre pMA91pyk in YEPD was grown to late log phase and cells harvested
IOOOxG 5 min 250ml aliquots. All cells were pooled and repelleted. 10g glass
beads (40 mesh) were added, +1mg PMSF,+ 1mg Benzamidine. The cells were
lysed with a motorised homogeniser for 20 min. Total cell lysis ascertained
microscopically. The beads were washed 10X with 20ml samples of extraction
buffer to remove ^ll traces of the enzyme. The sample was spun 5000xG 30
min to remove insoluble debris, made 40% saturated with (NH4)2S04, stirred for
four hours, then spun IOOOOxG for 30 min to pellet some of the contaminating
proteins. The supernatant was then made 70% saturated with (NH4)2S04,
stirred for four hours, then spun 10000xG 30 min. The pellet was resupended
in 5mls extraction buffer then desalted over a sephadex G-25 column 28.0 x 2.5
cm, pre-equilibrated with extraction buffer. The sample was recovered in a
volume of 50-60 mis, so was concentrated using an amicon filter to 20 mis
before loading onto the cibacronBlue column. The protein sample from the
amicon was loaded onto the blue column and allowed to equlibrate for at least
1 hour to optimise protein/dye interaction, the column was then washed with
100 mis extraction buffer to remove all unbound proteins, then the pyruvate








The pyruvate kinase was eluted by allowing this buffer to flow through by
gravity, which took approximately 2 hours. The pyruvate kinase containing peak
was collected, pooled and concentrated using the amicon filter, to a volume of
10 mis, then again passed over the sephadex G-25 column to remove all
residual phosphoenolpyruvate and fructose 1,6 bisphosphate. The protein was
found to be most stable as an (NH4)2S04 pellet, so all pyruvate kinase
containing fractions were pooled and this was made 70% saturated with solid
(NH4)2S04, stirred for 1 hour then spun 15000xG 30 min to pellet protein, this
was then stored at room temperature as a pellet.
The" Mighty Small" SE200 protein gel apparatus (Hoefer Scientific,California)
was used throughout to run discontinuous SDS gels( Laemmli,1970). The gel
sandwich was assembled according to the manufacturer's instructions and
placed vertically on a glass plate which had been overlayed with a solution of
1% agarose in IX Tris-Glycine. This sealed the plates to prevent leakage of
the polyacrylamide gel. A 9% SOS-PAGE gel was usually employed to











Separating gel buffer (1.5M Tris-HCl pH8.8);
Tris base
Distilled water




Stacking gel buffer ( 0.5M Tris-HCl pH6.8);
Tris base 3.0g
Distilled water 200rals




2X Sample loading solution;




Distilled water to 10.Omls
Running (Tank) buffer;
Tr is base 12 . Og
glycine 57.6g
10% SDS 4Omls
Distilled water to 4 litres
Stain stock (1% coomassie-blue R-250);
Coomassie-Blue R250 2.0g
Distilled water 200ml
stir and filtess through Whatman no. 1 filter paper
Stain solution(0.125% w/v Coomassie blue, 50% v/v methanol, 10% v/v acetic acid)
1% Coomassie-blue R-250 62.5mls
Methanol 250.Omls
Acetic acid 50.Omls
Distilled water to 500.Omls
Destain solution (50% methanol, 10% acetic acid);
Methanol 500mls
Acetic acid lOOmls
Distilled water to 1 litre
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2.11.2. Sample preparation
Protein samples were diluted with an equal volume of sample loading buffer
and boiled for 5 min prior to loading the gel. The gel was run at a constant
current of 20mA until the dye front reached the bottom of the gel. Gels were
stained by soaking for 30 min in stain solution, then destained by shaking in
destain at 50oC in a shaking water bath, with frequent renewal of the solution
until the gel background was colourless.
9% SOS-PAGE gels were used , these were made up as follows.
Separating gel(9%);
2.75ml 30% acrylamide stock




Stack ing gel(9% ) ;
0.57ml 30% acrylamide stock






The gel was run at 100V until the coomassie blue dyefront reached the
bottom of the gel. The gel was then removed from the running apparatus and
the plates prized apart using a spatula. The gel was immersed in stain solution
for 1 hour then destained in several changes of destain solution untiil the
protein bands were clearly defined and the background colourless.
2.11.4. PYRUVATE KINASE ASSAY
Pyruvate kinase was assayed by a modification of the method of Bucher and
Pfleiderer (1955). Assays were performed in a 1cm path length quartz cuvette in
a total volume of 1ml. The cuvette contained 6 ymol PEP, 6 ymol ADP, 0.25
ymol NADH, one unit of lactate dehydrogenase, 15 ymol MgS04, 100ymol KCI
and 50 ymol MES pH 6.2. The reaction was started by the addition of pyruvate
kinase and the progress monitored as the change in absorbance at 340nm.
84
chapter 3
3.1. SEQUENCING OF THE PYRUVATE KINASE GENE (PYK 1)
from Saccharomyces cerevisiae
3J ,T Background
The pyruvate kinase gene {pyk 7 from Saccharomyces cerevisiae had already
been sequenced prior to the outset of this project (Burke et ah 1983). This
sequence was used to design specific oligonucleotides to direct mutations
within the Ca1 helix of the intersubunit binding site. For these initial
experiments the Amersham site-directed mutagenesis kit was used. Repeated
rounds of mutagenesis failed to produce the desired mutations even though
the controls, which are an integral part of the mutagenesis kit, indicated that
the reactions were proceeding efficiently. When the mutagenic oligonucleotide
was then tested as a sequencing primer it was discovered that it did not prime
from the predicted point within the pyk 7 gene, but rather from a point within
the M13 genome. It was the assumed that this oligonucleotide had been
directing a non-lethal mutation within the M13 genome. Other oligonucleotides
produced no mutants and did not prime a DNA sequencing reaction. This
region of the gene was sequenced and discovered to be different from from
that of the original published sequence of Burke et at. Dr. A.J.P. Brown, and his
research group at the Department of Genetics, University of Glasgow, was also
making site specific mutants of the pyk 7 gene, using this is a model for
translational pausing and protein folding. The central tennet of this theory
requires a string of non-preferred codons within the coding sequence of a
gene. Such a string is postulated to induce a pause in translation allowing the
N-terminal part of the protein to fold before the C-terminal part is synthesised
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ACC ACC GAA ACC GTC GCT GCC TCC GCT GTC GCT GCT GTT
T T E TVAASAVAAVnew
TSLPR- old
Figure 13; The region of the pyruvate kinase gene found to be incorrect, the
corrected sequence and the effect upon the protein sequence.
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(Brown, 1987). The pyk 7 gene was a strong candidate for transational pausing
since it had 5 non-preferred codons in a row. Co-incidently these codons
were in the middle of the region of DNA which encodes the Ca1 helix.
Attempts to mutate this region by Dr. Browns group also met with failure. This
region was sequenced by Dr. Brown's group who also observed a deviation
from the original published DNA sequence. The sequence produced from both
our laboratory and that of Dr. Brown had three extra 'C' residues. These were
not arranged sequentially, so had the effect of putting the protein out of
reading-frame for 4 residues and creating an extra codon (fig 13). The new
sequence no longer contained any non-preferred codons making pyk 7 a poor
model for the translational pausing hypothesis.
3.1.2. The sequencing strategy
%
An essential requirement for oligonucleotide design in a mutagenesis
project is a good DNA sequence. It was therefore decided to resequence the
entire pyk 7 gene. The sequencing stratagy is summarised in fig 14 . The
region where the sequence discrepancy was found to occur was sequenced on
both strands of the DNA, using an oligonucleotide primer which primed 15bp 5'
to the first extra C residue in clone m13ab1 and by extending the reaction with
universal primer on the reverse clone m13ab2. The N-terminal part of the
coding sequence was cloned into m13 by exising the ecoRI fragment from
pPYK2E (fig 10) and cloning it into m13mp19, the resulting clone could then be
sequenced using univeral primer. No other sequencing discrepancies were
observed in any other part of the gene.
The region where the sequencing discrepancy was found to occur is very
'GC' rich and this encouraged compressions making the sequencing gels very










Figure 14; The sequencing stratagy employed to resequence the pykJ gene
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both Klenow DNA polymerase and Sequenase were used to direct the
sequencing reactions. Replacement of dGTP with dITP in the sequencing mixes
did not alleviate this problem. The problem was eventually solved, however, by
substituting dGTP with the synthetic nucleotide, 7-deazadGTP. Recent
developments in DNA sequencing technology have developed the enzymes BST
polymerase and TAQ polymerase. These enzymes can polymerise the DNA with
high fidelity at temperatures up to 70°C, such that compression problems
which result from strong secondary structures within the single stranded DNA
are alleviated. The revised DNA sequence has been published, see McNally et
al. 1989 in the appendix to this thesis. The sequence has been, submitted to
EMBL and has been given the accession number x14400.
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chapter 4
4.1. GENETIC MANIPULATION OF THE HOST YEAST STRAIN
4.1.1 Gene disruption of the pykl gene from Saccharomyces cerevisiae
When planning to overexpress any mutant yeast proteins in a homologous
background it is desirable to utilise a host strain which is phenotypically
mutant in the allele under investigation. Whenever possible it is advisable to
utilise a strain which is totally deleted for the allele in question, such strains
are created in the laboratory if not already available. In the case of the pyk 7
gene this was not feasible for reasons that will be discussed at the end of this
chapter. Instead a phenotypic mutant of pyk7 was created by a process of
gene disruption. This simply involved cloning a uralll fragment into the central
BgIII site within the gene as described in figure 15. The resultant plasmid was
then linearised with HinDIII, the linear ends promoting recombination within the
genome. The strain SF747 was used as the host in these experiments, the
a*
genotype of this strain can be found in the Materials and Methods section of
this thesis.
Transformants from the gene disruption experiment took 12 days to grow.
In total 14 transformants were obtained by selection on yeast minimal medium
(Yo) lacking uracil with 3% glycerol and 3% ethanol as the carbon sources.
The phenotypes of the disrupted strains are such that they can no longer
utilise glucose as a carbon source as glycolysis is blocked. These cells
accumulate a large quantity of phosphoenolpyruvate and die, however small
carbon compounds which can enter the cell serve as alternatives. The lack of
uracil in the medium selects for integrants within the pyk 7 locus. The
transformants were tested for growth on glucose to test for functional pyk.





















Figure 15; The mechanism of gene disruption.
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these were all ura + suggests that the uralll gene has recombined at another
site on the chromosome, possibly the uralll locus itself.
4.1.2. Verification of potential disruptants.
Chromosomal DNA was prepared from the nine clones which looked
promising from the nutritional selection tests. The DNA was cut with the
restriction enzyme HinDIII and electrophoresed on a 1% agarose gel. The
agarose gel was then Southern blotted and probed with the wild type pyruvate
kinase gene in the plasmid pPYK20. The Southern is shown in figure 16. Two
bands are apparent on this blot, the lower band can be attributed to the pyk 1
gene and the upper band, either to an incomplete digest or some
Sgalactosidase homologue.
4,1.3. Optimising cell growth
Growth of the cells on glycerol and ethanol was very slow, colonies taking
around five days to form on solid media. Ethanol is highly volatile and over
prolonged incubation at 30° may evaporate from the medium. Glycerol is
notoriously difficult to handle with any degree of accuracy. This prompted the
investigation of a better growth medium.
Pyruvate ethyl ester was tested as a carbon source, the rationale being that
this would enter the cell readily, being uncharged, and be broken down by
non-specific esterases within the cell to yield pyruvate and acetate which could
then serve as carbon sources to the cell. This compound was tested at
concentration of 0.1-4.0%, but did not sustain cell growth. This must be
because the ester is not entering the cell since both pyruvate and acetate
alone are reported to support cell growth.





Figure 16; Southern blot of HinOIII ONA extracted from yeast clones
obtained from gene disruption proed with a fragment of the pyk1 gene. The
wild type control in lane 7 illustrates that the pyk1 gene is found on a 7Kb
fragment. Lanes 1 - 6 demonstrate that in all but one case, the pyk-
phenotype is associated with the insertion of the 1.2Kb ura3 fragment resulting
in an 8.2Kb product. The clone in lane 3 appears to have undergone a deletion
which resulted in the pyk- phenotype.
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Concentrations from 0.1% to 4% were tested to ascertain which permitted most
extensive growth of the yeast strain. 2% pyruvate was seen to be the most
effective growth substrate, higher concentrations eventually became inhibitory.
There is no specific carrier for pyruvate in the yeast cell membrane, however
pyruvate can enter the cell via the lactate/proton symporter in the membrane
(Cassio et at, 1987) Pyruvic acid was made up as a fresh 20% stock in distilled
water then filter sterilised immediately prior to use. Old pyruvate would not
serve as an effective carbon source, nor would pyruvate that had been
autoclaved.
1
4.1.4. growth of dirupted strain
Growth of the disrupted yeast strain was compared with that of the parent
strain ton synthetic medium + 2% pyruvate, both strains grew at a very similar
rate, reaching the same cell density in stationary phase. This is further
evidence to suggest that the only difference between the disrupted and non-
disrupted strains is the loss of ability to grow on glucose. This strain was-
deemed suitable to use as a phenotypically pyk- background in which to
overexpress mutant pyogenes.
4.2. ADVANTAGES OF DELETION OVER DISRUPTION
Gene disruption is not the best technique to use for the purposes of this
project, ie. overexpression of mutant proteins in a homologous background.
Gene deletion is by far the method of choice. This is because, in the case of
the gene disruption there is a small chance that recombination may occur
between the mutant gene on a multicopy plasmid and the wild type gene which
is present, although disrupted, in the genome. This could result in a wildtype
gene on the multicopy plasmid which could quickly overgrow a cell population
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if the mutant gene was in some way compromised compared to the wild type.
Attempts to create a strain of yeast deleted in the pyk 7 locus failed to
produce any transformants. It was initially assumed that this was due to a
cloning abberation at one of the early stages in the process, however, this
approach has also been attempted in another laboratory (Dr. A.J.P. Brown
personal communication) with no success. This absolute requirement for pyk 7
would not seem to be at the protein level as the disrupted strain of yeast has
no active pyruvate kinase yet is viable. It is postulated that it may be the 5'
end of either the DNA or the mRNA which is important for cell survival. This
phenomenon is currently under study in Dr. Brown's laboratory.
Disruptants were further characterised by determining whether any active
pyruvate kinase was produced by the disrupted strains. A 10ml culture was
grown under appropriate selection, the cellls harvested and lysed as described
in section 2.10.1. The debris removed by centrifugation and the supernatant
assayed for the presence of active pyruvate kinase by the method described in
2.11.4. No active enzyme was ever found.
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chapter 5
5.1. THE OVEREXPRESSION OF PYRUVATE KINASE
5.1.1.
_ Attempts to overexpress the protein under the control of its own
prompter
Pyruvate kinase was initially overexpressed from the Saccharomyces
cerevisiae/E.coli shuttle vector pJDB207 (Beggs et at, 1983), the plasmid
pAYE434 comprised the pJDB207 shuttle vector with a 7kb Hindlll fragment of
Saccharomyces cerevisiae DNA which was known to bear the pykl gene. This
plasmid is shown in fig 12.
The vector pJDB207 is a high copy number vector containing the Ieu2d
allele. This allele is known to increase plasmid copy number. The precise
mechanism is not known but it is speculated that, since this allele is mutant,
only those clones where the vector has increased copy number can
successfully complement the leu phenotype of the host strain. Overexpression
of proteins in this vector is by virtue of the high copy number as the vector
contains no promoter sequences. Thus the overexpression of pyruvate kinase is
■'if
directed by its own upstream sequences.
The strain SF747[ pyk 1 ::ura/l/i was transformed with the plasmid pAYE434, by
sphaeroplast transformation as described in the 'methods' section of this thesis.
Transformants were initially selected on omission medium with pyruvate as the
carbon source and lacking leucine and uracil. All transformants were then
tested on omission medium with glucose as the carbon source, lacking leucine
and uracil. In no case were any transformants found to grow on pyruvate but
not glucose, indicating the presence of a functional pyk 1 gene. The repeated
selection for uracil and leucine ensured that the chromosomal copy of the pykl
gene remained disrupted and therefore non- functional, and that the clones
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retained the plasmid. Additional controls to ensure that the transformants were
genuine included plasmid rescue and restriction mapping. Initially, in all cases
the plasmid pAYE434 was rescued from the yeast strain intact as far as could
be determined by restriction mapping.
Protein was purified from both SF747 and SF747 + pAYE434 to determine
the level of overexpression of pyruvate kinase. The level in the transformed
strain was determined to be between 12 and 20 fold greater than in the SF747
strain. Protein gels of the cell extracts were difficult to interpret, as the levels
of overexpression were not sufficiently high to identify, unambiguously, an
increased level of pyruvate kinase by coomasie blue staining.
The transformed cells were stored at 4°C for a number of months before
being used to seed cultures for large scale protein production. The protein
preparation yielded only small quantities of pyruvate kinase, similar to the
amounts expected for wild type strains. Repeated retransformations yielded
positive transformants, but the levels of protein overexpression always
decreases on large scale culture or on storage at 4°C. Other workers in this
9
field also reported this problem, that when pyruvate kinase is overexpressed
from its own promoter, the levels of protein overproduction decreased with
time and culture (Dr. A.J.P. Brown, Mr. T.A. Murcott, personal communications).
5,1.2.0verexpression under the control of the pgk promoter.
Another pyruvate kinase clone was obtained, this one having the entire
pyruvate kinase coding sequence under the control of the pgk promoter. This
plasmid, pMA91pyk, derived from the shuttle vector pMA91 is illustrated in fig
12.
The pgk promoter is one of the strongest known in S.cerevisiae permitting
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expression of PGK to up to 80% of the total cell protein when present on a
multicopy vector ( Mellor, et aK 1986). Transformation of this plasmid into the
strain SF747 permitted massive overexpression of pyruvate kinase, to around
30% of the total cell protein, several hundred fold higher than wild type levels
(fig 17) . This strain served as an excellent source of wild type pyruvate kinase
protein in this project. This strain of yeast, SF747 + pMA91pyk, was tested for
growth compared to the non-transformed strain SF747. The transformed strain
demonstrated no reduction in growth rate as compared with non-transformed
strain, clearly demonstrating that the overexpression of pyruvate kinase protein
is in no way detrimental to cell growth. It may therefor be deduced that it is
the 5' end of the pykl which is responsable for the reduction in expression
observed when SF747 is transformed with pAYE434. Work is currently
underway to establish the nature of this decreased expression.
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Figure 17; The left hand side illustrates the level of overexpression of
pyruvate kinase from the shuttle vector pMA91. Small scale extracts were
prepared as described in the materials and methods section (2.10.1.). The
marker on the right hand side is cat muscle pyruvate kinase, supplied by Sigma.
The right hand side shows a sample of pyruvate kinase purified by cibacronblue
chromatography. The first two lanes represent 100ug and 500pg of protein,
the third lane shows 500pg of the same preparation after storage had reduced




The main purpose of this research project was to probe the allosteric
control of the enzyme pyruvate kinase using site-directed mutagenesis
techniques. The plan was to synthesize mutants of the enzyme within the 1,3
intersubunit interface: more specifically, within the Cal and Ca2 helices.
6.1.2. Initial attempts at Mutagenesis
Oligonucleotides to direct these mutations were originally designed using
the original published sequence of the pyruvate kinase gene of Burke et al.
(1983). These initial attempts at mutagenesis were unsuccessful!; of three
18mer oligonucleotides purchased to direct mutations within this area, only one
would direct a mutation. Sequencing of a large number of putative mutant
plaques obtained from a round of mutagenesis using the Amersham M13
mutagenesis kit did not reveal the expected mutation, even though the
reactions appeared to proceed efficiently as judged by the integral controls
within the kit. The oligonucleotides were used as sequencing primers using
M13ab1 as the template. The two oligonucleotides which were previously
shown not to direct a mutagenesis reaction would not function as sequencing
primers. This suggests that the mutagenesis was failing due to inefficient
hybridisation of the mutagenic oligonucleotide to the template DNA, the first
step in any mutagenesis reaction. The oligonucleotide which did direct a
mutation also functioned as a primer for de novo DNA synthesis. However, the
oligonucleotide bound within the M13 vector sequence and not at the expected
position within the pyruvate kinase gene. This would explain the fact that
although a large number of putative mutant plaques were screened, the
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expected mutation was not detected. It would now appear that a mutation was
directed by this oligonucleotide but was not detected by screening as it was
located within the M13 vector sequence.
6J_.3. Mutagenesis within the active site of Pyruvate kinase
As mutagenesis within the region of the 1,3 intersubunit interface of the
protein was hampered by the errors within the original published sequence,
attention was focussed on the active site of the enzyme in an attempt to
determine the role of the putative catalytic lysine residue 269.
Two oligonucleotides were designed to change lysine 269 to arginine and
histidine. These oligonucleotide were 18 base pairs long. The sequences of
the oligonucleotides used are illustrated below. The rationale behind these
changes was to maintain the positive charge within the active site as this is
probobly required for enzymatic function, but to alter its location and study the
effect on catalysis. In the case of the histidine which has a much lower pK
than that of lysine and arginine and may not have been expected to be
protonated at physiological pH, this change was postulated to alter the pH
profile of the enzyme.
Mutagenesis was again carried out using the Amersham site-directed
mutagenesis kit. However neither of these oligonucleotides would direct
mutations within the active site of the enzyme. The sequence around this
region of the active site was checked and found to be correct. The design of
the oligonucleotides was also verified and no obvious errors were detected. In
view of the previous lack of success with the mutagenesis reactions, the
method of mutagenesis was changed from the Amersham kit, which is
expensive and inflexible, to the Kunkel method of mutagenesis ( Kunkel, 1985).
This method is described in the methods section of this thesis. Attempts to
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use these mutagenic oligonucleotides as sequencing primers again met with no
success, this result could not be readily explained. Figure 18 shows the result
of a dot-blot performed using one of the mutagenic oligonucleotides as a
probe against M13ab1, the template for the mutagenesis reaction and M13ab2,
the reverse of this clone. This result suggests that the oligonucleotides can
bind to the template DNA , but cannot act as primers for de novo DNA
synthesis. The fact that the oligonucleotide does not bind to the reverse clone
also strongly suggests that this binding is specific to the pyk 1 fragment and
not to vector sequences.
Three theories were proposed to suggest why the oligonucleotide might
bind to the DNA yet not prime de novo DNA synthesis;
1. The oligonucleotide is not binding to the DNA under the conditions for
DNA sequencing, this may be because the oligonucleotide is too short and/ or
not sufficiently GC rich to form a suitable primer for de novo DNA synthesis.
2. The 3' end of the oligonucleotide may be blocked in some way as to
prevent polymerisation.
3. There may be a region of extensive secondary structure within the
template which blocks polymerisation from this end of the gene.
Reports from other workers within and outwith our department confirm that
oligonucleotides of this length and this complexity should be able to direct
mutations. The commercially available M13 reverse sequencing primer is
shorter, being a 17mer, and less GC rich than at least one of the failed
oligonucleotides (35%) yet can still be used as an efficient sequencing primer
suggesting that the problem is more complex than purely instability.
A report from the OSWELL DNA synthesis service, which provided all of the
oligonucleotides used in this project, suggests that this first theory is unlikely.
102
Figure 18; Dotblot of ml3pyk single stranded ONA probed with the 19mer
oligonucleotide which could not be used as a sequencing primer or to produce
mutants. Dots 1 and 3 are m13ab1 which produces single stranded DNA in the
opposite sense to the oligonucleotide, dot 2 is m13ab2 which is the same
sense as the oligonucleotide, and is present as the non-specific binding
control. lOOng of each clone were applied to the filter.
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Oligonucleotides are synthesised in the 3' to 5' direction, the 3' end of the
oligonucleotide being attached to a solid support. Once synthesis is complete
the oligonucleotide is liberated by a simple hydrolysis reaction to yield the free
3'end. The chances of this simple process going wrong are said to be minimal.
An HPLC elution profile of a small sample of the oligonucleotide used as a
probe in the dot-blot shows that the synthesis has worked perfectly. The
profile shows a single discrete peak migrating in the expected position of an
unblocked 18mer. Were the 3' end of the oligonucleotide still blocked, this
would not be the case.
This leaves the third theory, that there is an element of secondary structure
downstream to the position of the bound oligonucleotide which prevents
polymerisation. This may indeed be the case, but is very difficult to prove.
Agarose gel mobility studies of the single stranded DNA template did not
reveal anomalous mobility indicative of an extensive secondary structure. The
UWGCG computer package includes a number of computer programmes
designed to identify secondary structures within RNA. These programmes, such
as mountains, squiggles and stemloops should be readily applicable to single
stranded DNA molecules. Analysis of the pyruvate kinase template DNA using
the programme STEMLOOP reveals a potential stemloop at the region of the
template where the oligonucleotide binds, however there are also a large
number of other potential stemloops within the DNA strand and the
significance of this particular structure cannot be tested.
A new set of oligonucleotides were obtained. These were 29 base pairs in
length. Their sequences are listed in the table below. These oligonucleotides
were very effective as both sequencing primers and mutagenic
oligonucleotides. The fact that these longer oligonucleotides were effective
primers is evidence for the presence of an element of secondary structure
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within the template DNA. Presumably the longer 3' end of the oligonucleotide
possesses a stronger bonding energy, making the pairing of the template
strand of the DNA more favourable than bonding of the template to itself.
Putative mutant plaques were selected for sequencing by single nucleotide
tracking. The efficiency of mutagenesis with these oligonucleotides, using the
Kunke! method of site directed mutagenesis, varied between 80-100%. This is
comparable to the efficiencies reported using the Amersham site- directed
mutagenesis kit, the most efficient mutagenesis method reported. A selection
of the plaques shown to be mutant by single nucleotide tracking were
sequenced using the sequenase DNA sequencing kit. An autoradiograph
produced from such a sequencing reaction is illustrated in figure 19 . The
mutation K269R changes the wild type sequence "CAAGAT" to "CAGAAT", the
region of the mutation is more than 200bp away from the sequencing primer
and sequences located this far away from the primer becomes very difficult to
read unambiguously. To circumvent this problem this mutant was also
screened by differential hybridisation using the radioactive mutagenic
oligonucleotide as a probe. The results of such a slotblot are shown in figure
20.
6.1.4. SITE-DIRECTED MUTAGENESIS IN THE INTERSUBUNIT INTERFACE.
With the initial problems surmounted and the sequence of the DNA around
the intersubunit interface confirmed, an attempt was made to produce
site-directed mutants within the intersubunit interface. Three mutations were
made in total. These were all directed against serine 414, the residue that
meets with itself across the 1,3 intersubunit interface as illustrated in figure 21
. This serine was changed to an arginine, in the hope of setting up a charge
repulsion which would destabilise the interface, and a histidine which might
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Figure 19; Sequencing autordiographs of wild type and the K269H mutant.
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Figure 20, Slotblot of the K269R mutant. Slot 8 contains single stranded
DNA prepared from wild type 13ab1 phage, slot 1,2,3,5,6 and 7 contain single
stranded DNA from putative mutant plaques. Slot 4 is a negative control
containing m13ab2 ONA which is in the same sense as the oligonuleotide. The
upper figure illustrates an autoradiographic exposure of a filter washed in 1x
SSC at room temperature, while the lower figure represents the same filter
filter after a O.lxSSC, 65° wash.
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tgure 21 Plot of pyruvate kinase with the serine residues across the 1,3
mtersubunit interface highlighted.
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serve the same purpose were the side chain charged a physiological pH, and
perhaps add an element of steric hinderance. This serine was also changed to
a proline. While it is commonly accepted that proline, as an imino acid, cannot
be accommodated within regular a helices, there are examples where they are
found, for example in the yeast phosphoglycerate mutase enzyme. The proline
in this enzyme has the effect of making the helix kink slightly. It was hoped
that the introduction of a proline residue into the Ca2 helix of pyruvate kinase
may cause the helix to kink in such a way that it was no longer possible for
the helices to form an effective interaction at the intersubunit interface. The
autoradiographs of the sequencing of these mutant of pyruvate kinase are
illustrated in figures 22-24.
6.1.5. OLIGONUCLEOTIDES USED FOR MUTAGENESIS
MUTATION OLIGONUCLEOTIDE MISMATCH LENGTH *GC Tm
ACTIVE SITE
WILDTYPE CATTGTCAAGATTGAAAACCAACAAGGTG - -
1. K269H CATTGTCCACATTGAAAAC 2 19 37 50
2. K26 9R CATTGTCAGAATTGAAAAC 2 19 32 4 8
3. K269H CATTGTCCACATTGAAAACCAACAAGGTG 2 28 43 58
4. K269R CATTGTCAGAATTGAAAACCAACAAGGTG 2 28 39 57
INTERSUBUNIT INTERFACE
WILDTYPE CCGTCGCTGCCTCCGCTGTCGCTGCTG - -
5. S414R CCGTCGCTGCCAGAGCTGTCGCTGCTG 3 27 70 69
6. S414H CCGTCGCTGCCCACGCTGTCGCTGCTG 2 2 7 7 4 71
7. S414P CCGTCGCTGCCCCAGCTGTCGCTGCTG 2 27 74 71
8. V411M CGAAACCATGGCTGCC - 16 6 3
9. A418T GCCTCCGCTTGGGTTTTC - 18 61
Tm was determined by the formula 69.5 + 0.41(%GC)-650/L, Oligonucleotides 1
and 2 did not direct mutations, while 8 and 9 were designed before errors in
the published sequence had been corrected. Where specific mutations are
refered to in the text, it is implied that these mutations were directed by
_ oligonucleotides 3-7.
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Figure 22; Autoradiograph of the mutant S414P. The wild type sequence is
illustrated in figure 13. While the sequence of this mutant is quite clear, a few
faint spurious bands are apparent, possibly as a result of the mutation which
introduced two more 'C' residues into a region of the DNA which is already
difficult to sequence due to its high 'GC' content.
S414h
Figure 23; The mutation S414H
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6.1.6. Conclusions.
Initial attempts at site directed mutagenesis met with failure due to
inaccurate publication of the original sequence data (Burke et a/. 1983). While
these errors were corrected, efforts at mutagenesis were directed at the active
site of the protein. Two 19mer oligonucleotides were obtained to direct the
mutations K269H and K269R. These oligonucleotides would not direct mutations
within the active site, nor would they act as primers for the generation of
sequence data by the dideoxy method. Longer oligonucletides were obtained,
and these served to direct mutations with high efficiency. The policy of using
longer oligonucleotides was adopted for mutagenesis within the intersubunit
interface, once the correct sequence had been confirmed. 5 mutatons have
been synthesised and verified. K269R and K269H are mutations of the putative
catalytic lysine residue, while S414R, S414H and S414P are all directed to a
serine residue within the intersubunit interface. The mutagenesis was
performed on a 1.2 Kb fragment of the pyk 7 gene, which was convenient for
cloning into the single stranded phage vector M13. A number of subcloning




Figure 24: The mutation S414R
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Chapter 7
7.1. SUBCLONING OF THE MUTATED DNA.
7.1.1. Production of mutant shuttle vectors
Only a small portion of the pyruvate kinase gene could be subcloned and
mutated in the M13 vector as discussed previously, Therefor the mutated
section of the gene had be subcloned to produce the mutated gene in the
expression vector pMA91pyk. A diagrammatic summary of this subcloning
process is shown in figure 25.
RF DNA was prepared from the mutant M13 clones as described in the
methods section of this thesis. The pyruvate kinase coding section of these
clones was excised from the RF DNA using the EcoRI and HinDIII site in the
polylinker. This DNA was cloned into the pUC derived plasmid pK19, a small
high copy plasmid bearing the kanamycin resistance gene. This plasmid was
used as a source of the mutated Bglll/BstEII fragment of the pyruvate kinase
gene. The high copy number of the plasmid ensures a high yield of the
fragment from CsCI gradients. This plasmid is easier to handle than M13RF
DNA which gives low yield in CsCI preparations and is highly susceptible to
recombination over prolonged growth periods.
The entire 7kb HinDIII fragment of yeast DNA comprising the pyk1 gene and
surrounding sequences was cloned into the plasmid pUC18. This plasmid,
pPYK20, is illustrated in the map in section 2 of this thesis. pPYK20 was cut to
completion with the enzymes Bglll and BstEII and the fragments separated by
slow electrophoresis on a 1% agarose gel. This digestion yielded a fragment
of 0.7kb which was the wild type Bglll/BstEll fragment and a larger fragment of
8.8kb, which comprised the rest of the pykl gene, surrounding sequences and
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vector DNA. Great care was taken to separate these fragments as carefully as
possible. DNA bands were excised from the agarose gel and purified as
described in the methods section of this thesis. Controls were performed to
ensure that the 8.8Kb fragment could not recircularise by ligating an aliquot of
the DNA and transforming into competent bacterial cells. Only batches of the
8.8Kb fragment which, when transformed into competent cells, produced no
bacterial colonies were used for subsequent ligation experiments.
Mutant Bglll/BstEII fragments were produced by digestion of the appropriate
pK19pyk clone with these enzymes and subsequent electrophoresis and
purification as described previously.
These two DNA fragments were ligated together to form the relevant
mutant pPYK20 clones.
In the early stages of the project the plan was to then subclone the 7kb
Hindlll fragments from the mutant pPYK20 clones into the yeast/E. coli shuttle
vector pJDB207. This would permit the overexpression of the pyruvate kinase
gene from its own promoter. However, in light of the evidence discussed in
chapter 5, that this overexpression is transient,-a new strategy was adopted.
This involved the use of the expression vector pMA91pyk, which permits the
overexpression of the pyk7 gene from the yeast PGK promoter. A map of
pMA91pyk is illustrated in fig 12 of this thesis. pMA91pyk was digested with
the enzymes Bg 111 and Sstl to remove the wiidtype pyruvate kinase sequences.
The mutant pPYK20 plasmids were digested with these same enzymes to yield
the mutated pyk1 fragments. These were then ligated together to form the
mutant pMA91pyk clones. Due to lack of time only the plasmids
pMA91 pykS414P and pMA91 pykK269H were produced, however mutant pK19






Shaded areas represent the pyk1
structural gene
Figure 25 The subcloning proceedure required to produce a mutated gene
in an expression vector.
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7.1.2. VERIFICATION OF MUTANT SHUTTLE VECTORS
The subcloning process described above required that at two stages wild
type DNA be purified away from vector sequences. While careful controls were
carried out at every stage possible to ensure that there was no cross
contamination of mutant sequences with residual wild type, I felt it was
necessary to further ascertain that the mutant shuttle vectors pMA91 pykS414P
and pMA91 pykK269H were indeed mutant. There are three ways in which this
could be done;
1. Double stranded plasmid sequencing
2. Differential hybridisation with the mutagenic oligonucleotide
3. Transformation of yeast, production of protein subsequent kinetic
characterization and comparison to wild type.
In this instance double stranded DNA sequencing would only be possible for
one of the mutants, pMA91pykS414P, as an oligonucleotide was available which
would prime 5' to the mutated region to yield suitable DNA sequence
information. There was no suitable primer available to screen the mutant
pMA91 pykK269H in this way. Thus it was decided to adopt the second method
described above namely, differential hybridisation with the mutant
oligonucleotide. This experiment gave very unsatisfactory results. Blots were
prepared with Bglll/BstEII digests of all clones. Each blot contained samples of
DNA from the putative mutant shuttle plasmid, the relevant mutant pKpyk clone,
the mutant RF DNA, wild type pMA91pyk and wild type pPYK20. In each case
the oligonucleotide bound only to the 0.7Kb DNA fragment as expected,
however it was impossible to obtain a differential removal of the
oligonucleotide probe no matter how carefully the washing procedure was
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carried out. At low stringency the oligonucleotide bound to all sequences with
similar avidity, however increasing the stringency of washing to well below that
approximated by calculation of the Tm of each oligonucleotide, they bound
tenaciously to all samples with a similar avidity until eventually dissociating
from the positive and negative controls and test samples at very low
stringencies, O.OIxSSC, 70°C. This experiment was repeated four times, once
by another worker in the laboratory, in an attempt to rule out operator error,
however the same result was obtained in every case. The mutant M13ab1
clones were both resequenced and found give the correct mutant sequences as
expected. The Tm of oligonucleotides is commonly calculated by the Wallace
rule,
Dissociation temperature of an oligonucleotide in 1M Na+
Tm = 4x(No. of GC base pairs) + 2x(No. of AT base pairs)
This gives an approximation of the dissociation temperature of oligonucleotides
of between 12 arrd 23 base pairs and is not recommended for use with
oligonucleotides outwith this size range. The oligonucleotides used in these
experiments are 27mers and 29mers and thus are not governed by the Wallace
rule. Another approximation of Tm for mismatch oligonucleotides is the
formula
Tm = 69.3 + 0.41(G+C%) - 650/L
where L is the length of the oligonucleotide in base pairs, bearing in mind that
the Tm of a duplex decreases by 1°C with with every increase of 1% in the
number of mismatched base pairs.
Using these considerations, the Tm for the oligonucleotide S414P should be
around 68°C in 1X SSC, and K269H around 56°C in the same salt conditions.
The oligonucleotides were observed remain bound to the template at these
temperatures in 0.1XSSC and in 0.01XSSC.
On reflection these oligonucleotides appear to be too long to be useful as
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probes in this kind of differential hybridisation experiment. However, even
though this method of screening was unsuccessful, an attempt was made to
transform the putative mutant clones into yeast to examine any changes in the
pyruvate kinase enzyme, the third charaterisation method described above.
7.2. TRANSFORMATION OF MUTANTS INTO YEAST
7.2.1. Production of transformants
While the results of the differential hybridisation were unsatisfactory, all the
evidence from the subcloning controls suggests that the final product of the
subcloning is very likely to be mutant. Thus it was decided to proceed with
these clones and transform them into the disrupted yeast strain. Yeast
transformations were performed by the method of Ito as described in the
t
methods section of this thesis. All transformations were set up in the
presence of a negative control comprising yeast cells with no DNA added.
Plates were incubated at 30°C under selective conditions to allow only the
growth of transformed yeast colonies. In the case of the transformation of the
putative mutant yeasts, it took 20 days for colonies to appear on the growth
plates. No colonies grew on the negative control plates with no DNA added.
S414P produced 120 colonies and K269H, 200 colonies for approximately 5pg of
DNA. These transformation efficiencies are rather low compared to those
reported in the literature, however yeast transformation efficiency is known to
vary greatly with different batches of polyethyleneglycol and transformation of
plasmids bearing the Ieu2d allele is always very inefficent by this particular
method.
Unfortunately it has proved impossible to subculture any of the mutant
transformants obtained. There was no time to look into this further.
Chapter 8
8.1.PROTEIN PURIFICATION
8.1.1. Purification of pyruvate kinase from Saccharomyces cerevisiae
Pyruvate kinase has been purified from a great many sources (Guderley et
at, 1989) including the yeasts Saccharomyces cerevisiae and Saccharomyces
car/sbergensis (Yun et al. 1976, Roschlau et al. 1972, Haeckel et at. 1968). Most
methods utilise an affinity purification procedure using Cibacron-blue, an
affinity matrix which binds ADP binding proteins. The dye Cibacron-blue is
relatively inexpensive to buy, but affinity purification matrices such as
Cibacron-blue bound to Sepharose are very expensive. For this reason we
synthesised our own Cibacron-blue Sepharose in the laboratory.
8.1.2. Synthesis of Cibacron-blue sepharose-6B
A number of methods have been published describing the attachment of
cibacron-blue dye to chromatography matrices such as Sephadex, cellulose and
Sepharose. Sepharose was used in this case because of the ease of coupling
of the dye and the matrix, in that this did not require preincubation with
noxious chemical agents such as cyanogen-bromide. Cibacron-blue can be
rapidly and efficiently coupled to the matrix by incubation at high pH in high
salt as described in the methods section of this thesis. Unfortunately this
home made Cibacron-blue Sepharose was extremely heterogeneous regarding
its affinity for pyruvate kinase so a number of batches were synthesised before
one was deemed suitable for use. This particular batch retained 80% of the
total pyruvate kinase on the column initially, however this value dropped to
around 30% of the total sample over a period of two months. It is likely that
the column was becoming fouled by microorganisms. Pyruvate kinase is
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reported to be cold sensitive thus all purifications were carried out at room
temperature, this greatly facilitated the growth of microorganisms. Although all
buffers were treated with 0.05% sodium azide, this compound is light sensitive
and thus rapidly degraded. The components of the elution buffer used for the
cibacronblue column namely fructose-1,6-bisphosphate and
phosphoenolpyruvate are excellent substrates for microbial growth.
Elution of the pyruvate kinase from the Cibacron-blue Sepharose using the
specific elutants, fructose-1,6-bisphosphate and phosphoenolpyruvate as
described gave a homogeneously pure preparation of the enzyme as
determined by coomassie blue staining (Fig 17). The enzyme is produced at a
much higher specific activity than previously reported, a reflection of the
advantages of protein production from an overproducing strain.
Another factor is undoubtedly the fact that the enzyme is eluted from the
column in the presence of fructose-1,6-bisphosphate, an allosteric activator of
the enzyme. Although buffer containing the enzyme was exchanged by amicon
filtration, residual traces of fructose-1,6-bisphosphate would be expected to
alter the kinetics of the enzyme drastically.
An alternative method of purification of the enzyme was sought, which did
not rely on affinity elution from Cibacron-blue Sepharose. The anion exchange
medium, Q Sepharose was utilised on the advice of Dr. T. Murcott of the
department of biochemistry, University of Bristol. The purification protocol is
similar to that described in section 2.10 of this thesis, except that teh
cibacron-blue chromatography step is replace by a Q sepharose step in which
the protein is equilibrated with 50mM Tris-CI pH 8.5, 50mM KCI, 5mM EDTA,
0.05mM PMSF, and O.ImM Benzamidine. Pyruvate kinase elutes with the
breakthrough volume, and over 85% of the activity applied to the column is
recovered. The protein is recovered greater than 90% pure as determined by
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SDS-PAGE. The kinetic parameters were determined to be; KmPEP 4mM, Km
ADP 1mM, and SA 382 units per mg protein.
There are several advantages to using the pyruvate kinase produced by this
method, even over that which is purer from the affinity elution procedure.
Cibacronblue binds many proteins, mostly those that bind ATP or fructose
compounds. Trace amounts of these proteins in the pyruvate kinase
preparation, even in concentrations so small as to not be discernable by
coomassie staining, may significantly skew kinetic analyses, if the
contaminating protein had a higher affinity for ADP for example. Q Sepharose
binds proteins on the basis of their ionic charge, although a few minor proteins
are observed to copurify with pyruvate kinase using the protocol described,
these are unlikely to have common substrate binding properties and thus are
unlikely to interfere in kinetic analyses of enzyme activity.
The protein produced by the Q Sepharose method appears to be stable.
Pyruvate kinase from Saccharomyces cerevisiae is notoriously unstable,
especially in the presence of fructose-1,6-bisphosphate and in the cold
(Hunsley and Seulter, 1969, Yun et aK 1976). Protein produced by the
cibacron-blue method, while appearing to be pure, lost at least 25% of its
enzymic activity within 2 weeks of purefication. SDS-page analysis of a sample
of the protein which had incurred a reduction of activity upon storage showed
that the protein ran similarly to a freshly prepared preparation suggesting that





The investigation of the allosteric nature of pyruvate kinase is an extensive
project and could not be expected to be completed within the limited timespan
of a single PhD project. The work presented here describes the setting up of
an effective system for these studies. This preliminary work proved to be
much more time consuming than originally planned, due to a number of
problems encountered during the course of this project. The first hurdle
encountered was the error in the published sequence of the protein. This
affected the progress dramatically as the error occurred in the region of the
gene which encodes the 1,3 intersubunit interface. Problems were also
encountered when trying to mutate outwith this region, .however these were
overcome by the use of longer mutagenic oligonucleotides. Overexpression of
pyruvate kinase also proved to be less straightforward as originally anticipated
due to the dosage compensation and other regulatory effects observed when
the protein is expressed by its own promoter. This problem has now been
alleviated with the use of the fusion product of the pgk promoter and the pykl
structural gene. This work is to be continued by Mr. Richard Collins, who
should find it relatively easy, following the procedures outlined here, to express
the mutant pyruvate kinases described herein, and then examine the effects of
the mutations on the kinetics of the enzyme.
Expression and purification of the active site mutants described in this
thesis should identify the essential residues within the active site of the protein
such that the catalytic mechanism may be affirmed unambiguously.
There is still a lot of scope for mutagenesis of the Ca1 a-nd Ca2 helices to
assign their role in the allosteric transition. In recent years saturation
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mutagenesis methods have become increasingly popular and this technique
could lend itself particularly well to these studies. Saturation mutagenesis of
the Ca1 and the Ca2 helices followed by transformation into the pyk strain of
yeast would reveal those mutations which yielded a functional pyruvate kinase
protein. This could then be purified on a small scale to attest its sensitivity to
allosteric effectors.
It may be the case that the Ca1 and Cct2 helices of the protein are not
solely responsible for the allosteric nature of the yeast enzyme. It is therefor
necessary to identify other important residues or regions of the protein in this
respect, and perhaps subject them to mutagenesis.
The role of the N terminus in the regulation of other forms of the enzyme
should also be investigated. The yeast enzyme has a truncated N terminus
when compared to all other known forms. The N terminus is known to be the
site of phosphorylation of the liver isoenzyme, and this phosphorylation event
is known to have effects on the catalytic activity of the enzyme (section 1.1.3.).
It would be interesting to alter the N terminus of the yeast enzyme by fusing
. .-f.
on additional residues to make it more similar to the N-termini of some of the
mammalian isoenzymes, and to analyse any effect on the kinetics of the
enzyme. It may also be possible to swap N terminal domains of other pyruvate
kinases and attest the effects of this on the kinetics of the enzyme. Clearly
there is a great deal of work to be carried out, using pyruvate kinase as a
model for allosteric control now that the groundwork required for the efficient
production of mutant proteins has been completed
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The yeast pyruvate kinase gene does not contain a string of non-
preferred codons: revised nucleotide sequence
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The sequence of the gene encoding pyruvate kinase from Saccharomyces cerevisiae was re-determined because of failures
with oligonucleotide-directed mutagenesis experiments involving a region thought to contain a string of five contiguous
non-preferred codons. This region was found to be difficult to sequence and was shown to have three extra bases when
compared with the published sequence [(1983) J. Biol. Chem. 258, 2193-2201]. The revised sequence demonstrates that
the yeast pyruvate kinase gene does not have a cluster of non-preferred codons, and that it therefore is not an example
of the class of genes which possibly exhibit translational control by the presence of non-preferred codons.
Pyruvate kinase gene; Nucleotide sequence; Translational control; Non-preferred codon; (Saccharomyces cerevisiae)
1. INTRODUCTION
Pyruvate kinase has been extensively studied
because of its abundance in most organisms and
because of its importance in glycolysis for control¬
ling the flux from fructose 1,6-bisphosphate
through to pyruvate. The enzyme catalyses the
essentially irreversible conversion of phosphoe«o/-
pyruvate to pyruvate by the addition of a proton
and the loss of a phospho group, which is transfer¬
red to ADP. The high resolution crystal structure
of mammalian muscle pyruvate kinase has been
determined and correlated with the protein se¬
quence [1]. Amino acid sequences deduced from
DNA sequences are also available for all four
Correspondence address: A.J.P. Brown, Institute of Genetics,
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The nucleotide sequence presented here will appear in the
EMBL/GenBank database under the accession no. X14400
mammalian isoenzymes [2-61], and for pyruvate
kinase from chicken [7] and from Saccharomyces
cerevisiae [8],
A notable feature of the yeast pyruvate kinase
DNA sequence previously reported [8] is that it has
an unusual arrangement of five consecutive non-
preferred codons (as defined by Bennetzen and
Hall [9]) located approximately four-fifths of the
way through the coding region. This provided in¬
direct evidence for the possibility that the gene may
possess a translational pause in this region, thus
enabling the multidomain structure of the enzyme
to fold correctly during translation [10], Experi¬
ments were devised by the Glasgow group to test
this hypothesis by site-directed mutagenesis to re¬
place the non-preferred codons with the synony¬
mous preferred codons. Three oligonucleotides
were synthesised for this purpose, but they failed to
give the appropriate mutants, and their Tm values
seemed to be lower than theoretically expected
[11]. By coincidence, site-directed mutagenesis ex¬
periments involving the same region were being
done by the Edinburgh group to study intersubunit
contacts and allosteric control of pyruvate kinase.
It was decided to re-examine the DNA sequence in
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this region, and eventually to re-determine the en¬
tire sequence.
2. EXPERIMENTAL
The plasmid pAYE4(34) (fig.l), which corresponds to the S.
cerevisiae PYK1 gene cloned into the multicopy vector pJDB207
[12], was generously provided by R. Cafferkey, A. Goddey and
B. Carter formerly of G.D. Searle. Suitable restriction frag¬
ments were subcloned into phage Ml3 for sequence determi¬
nation by the dideoxy method. The oligonucleotides used by the
Glasgow group were synthesised by V. Math, A.J.P. Brown and
J.R. Coggins (Departments of Biochemistry and Genetics,
University of Glasgow); those used by the Edinburgh group
were from Oswel DNA Service, University of Edinburgh.
Site-directed mutagenesis was done by the Glasgow group in
an attempt to replace the contiguous string of five non-preferred
codons in PYK1 in the proposed 'pause region' [10] with the
synonymous preferred codons. The procedures of Winter et al.
[13] were used. Following mutagenesis, phages were screened by
plaque hydridisation with the 3:P-end labelled mutagenic
oligonucleotide as a probe. Filters were serially washed at in¬
creasing temperatures, and autoradiographed between each
wash [14], The expected 7",„ value for the wild-type PYK1 se¬
quence was 37°C, whereas that for the mutant was 74°C. In
fact, the plaques displayed a range of Tm values intermediate
between these two extremes. Several putative mutant phages
were sequenced with the use of a 14-mer primer of the sequence
5'-TGTACTCCAAAGCC-3' which hybridises 16 nucleotides
upstream from the 'pause region'. To our surprise the sequences
neither contained the published wild-type nor the expected
modified sequences. Instead, all contained three extra C-
residues interspersed with the wild-type 'pause' sequence (fig.2).
Sequencing of the original plasmid pAYE4(34) in this region
established that the sequence differences did not arise during the
multiple subcloning steps during the mutagenesis experiments.
The Edinburgh group independently confirmed the presence of
the extra C-residues with a different sequencing primer.
3. RESULTS AND DISCUSSION
3.1. Nucleotide sequence of PYK1 gene
The strategy used to sequence the PYK1 gene is
summarised in fig.l. A contiguous stretch of 1791
bases was sequenced which includes an open
reading frame of 1500 bases encoding the enzyme
pyruvate kinase (fig.2). The sequence is identical to
the previously published sequence [8] except for
three extra C-residues located between codons 379
and 386. These sequence changes have the conse¬
quence that the five non-preferred codons are con¬
verted to six preferred codons.
Both the Glasgow and Edinburgh groups found
that the results of DNA sequencing reactions in this
region were unusually difficult to interpret (fig.3).
This was true with the use of different primers and
Fig. 1. The yeast/E. coli shuttle plasmid pAYE4(34) with a 7 kbp
insert encoding the yeast PYK1 gene. The two EcoRI restriction
fragments covering the entire PYK1 coding sequence were
subcloned individually into pAT153 and subsequently into
M13mpl9 in two orientations to allow sequencing of both
strands. In addition, the BgtU/EcoRl fragment containing the
sequence differences was cloned into M13mpl8 and M13mpl9
to allow for detailed analysis of the region. The contig diagram
illustrates the sequencing strategy. Universal sequencing primers
were used, as well as oligonucleotides synthesised for use in the
mutagenesis studies. The shaded region shows where the three
extra 'C'-residues are located. This region of the DNA has been
sequenced extensively on both strands using either the Klenow
fragment of DNA polymerase or Sequenase.
with different DNA polymerases. It seems likely
that these residues were missed with the sequencing
conditions used by Burke et al. [8]. An additional
and different line of evidence in support of this
suggestion comes from the fact that the revised se¬
quence is more similar to pyruvate kinase se¬
quences from other organisms (fig.4).
3.2. Translationalpauses specified by non-
preferred codons
It is clear from these results that pyruvate kinase
no longer provides strong indirect evidence to sup¬
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AA7 GTCi 1AGAT TAGAAAGA77GACC7CA77AAACG77G7TGCTGGTTCTGACT7GAGAAGAACCTCCATCA7T6GTACCATCGGTCCAAAGACCAACAACCCAGAAACCTTGGTTGCTTT
1 10 20 30
MSRLERLTSLNVVAGSDLRRTS I IGTIGF K TNNPETLVAL-
GAGAAAGGCTGGTTTGAACATTGTCCGTATGAAC7 7C7 C7CACGGTTCTTACGAATACCACAAGTCTGTCATTGACAACGCCAGAAAGTCCGAAGAATTGTACCCAGGTAGACCATTGGC
40 5" 60 70
RK AGLN I VRMNF SHGSYE YHK S V I DNARK SEELYPGRPLA-
CATTGCTTTGGACACCAAGGGTCCAGAAATCAGAAr.TGGTACCACCACCAACGATGTTGACTACCCAATCCCACCAAACCACGAAATGATCTTCACCACCGATGACAAGTACGCTAAGGC
80 90 100 1 10
IALDTK GPE I RT GTTTNDVDYP I PPNHEM I FTTDDK YAK A —
TTGTGACGACAAGATCATGTACGTTGACTACAAGAACATCACCAAGGTCATCTCCGCTGGTAGAATCATCTACGTTGATGATGGTGTTTTGTCTTTCCAAGTTTTGGAAGTCGTTGACGA
120 130 140 130
C D D K IMYVDYKNITKVISAGRI IYVDDGVLSFGVLEVVDD-
CAAGACTTTGAAGGTCAAGGCTTTGAACGCCGGTAAGA7CTGTTCCCACAAGGGTGTCAACT7 ACCAGGTACCGATGTCGATTTGCCAGCTTTGTCTGAAAAGGACAAGGAAGATTTGAG
160 170 180 190
K TLK V K ALNAGK I CSHK GVNLPGTDVDLPALSEK DK EDLR-
ATTCGGTGTCAAGAACGGTGTCCACATGGTCTTCGC.TTCTTTCATCAGAACCGCCAACGATGT TTTGACCATCAGAGAAGTCTTGGGTGAACAAGGTAAGGACGTCAAGATCATTGTCAA
200 210 220 230
FGVK NGVHMVF ASF I RT ANDVLT I REVLGEOGK DVK I IVK-
GATTGAAAACCAACAAGG7 GTTAACAACTTCGACGAAAT CTTGAAGGTCACTGACGGTGTTA7 GGTTGCCAGAGGTGACTTGGGTATTGAAATCCCAGCCCCAGAAGTCTTGGCTGTCCA
240 250 260 270
IENGQGVNNFL'E I LK VTDGVMVARGDLG I E IPAPEVLAVQ-
AAAGAAATTGATTGCTAAGTCTAACTTGGCT GGTAAGCCAGTTATCTGTGCTACCCAAATGTTGGAATCCATGACTTACAACCCAAGACCAACCAGAGCTGAAGTTTCCGATGTCGGTAA
280 290 300 310
KK L I A K SNLAGK PV I CAT GMLESMTYNPRPTRAEVSDVGN —
CGCTATCTTGGATGGTGCTGACTGTGTTATGTTG7 CTGGTGAAACCGCCAAGGGTAACTACCCAATCAACGCCGTTACCACTATGGCTGAAACCGCTGTCATTGCTGAACAAGCTATCGC
320 330 340 350
AILDGADCVMLSGETAKGNYPINAVTTMAETAVIAEQAIA-
TTACTTGCCAAACTACGATGACATGAGAAACTGTACTCCAAAGCCAACCTCCACCACCGAAACCGTCGCTGCCTCCGCTGTCGCTGCTGTTTTCGAACAAAAGGCCAAGGCTATCATTGT
360 370 38'"' 390
YLPNYDDMRNCTPK PTST TE TVAASAVAAVFEGK AK A I I V —
T S L P R —
CTTGTCCACTTCCGGTACCACCCCAAGATTGGTTTCCAAGTACAGACCAAACTGTCCAATCATCTTGGTTACCAGATGCCCAAGAGCTGCTAGATTCTCTCACTTGTACAGAGGTGTCTT
400 410 420 430
LST S GTTPRLVSK YRPNCP I I LVTRCPRAARFSHLYRGVF -
CCCATTCGTTTTCGAAAAGGAACCTGTCTCTGACTGGACTGATGATGTTGAAGCCCGTATCAACTTCGGTATTGAAAAGGCTAAGGAATTCGGTATCTTGAAGAAGGGT6ACACTTACGT
440 450 460 470






Fig.2. Nucleotide sequence and deduced amino acid sequence of PYK1. The three extra 'C'-residues found in this study are indicated
by the asterisks, and are discussed in the text.
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Fig.3. The results of dideoxy sequencing reactions with the
Klenow fragment of DNA polymerase in the region of the se¬
quence differences. The three 'C'-residues not reported in the
orginal sequence data are indicated by the asterisks, and appear
fainter than other C-residues in the same region. The use of
dITP instead of dGTP had no effect on this observation. Se-
quenase was only effective for sequencing this region when
7-deaza-dGTP was substituted for dGTP in the reaction mixes.
A C G T
translation and protein folding in vivo. However,
this does not mean that the hypothesis is no longer
tenable. The codon usage patterns in several other
yeast genes reveal significant contiguous strings of
non-preferred codons; these include AROl, GAL4
and TRP3 [10] as well as FAS], HIS4 and TRP5
(fig.5). In some genes the strings of non-preferred
codons seem to be preferentially located close to in-
terdomain regions {AROl, FAS1), whereas in
others no such correlations exist (GAL4, HIS4,
TRP5). In the latter cases it is possible that the
strings of non-preferred codons promote intra-
domain folding, but there is no evidence to support
this. It remains attractive to suggest that putative
translational pauses within the AROl and FAS1
genes temporally separate the synthesis, and hence
the folding, of their multiple structural domains in
vivo. As far as we know there is no direct evidence
yet that either invalidates or supports the hypo¬
thesis. The Glasgow group is attempting to provide
such evidence by mutating the string of ten non-







Yeast [8] ... C T P K P T S T T E T S L P R - ' A A V F E Q K A K A
Yeast - this report . . . C T P K P T S T T E T V A A S A V A A V F E Q K A K A
Chicken M [7) . . . H S V H H R E P A D A M A A G A V E A s F K c L A A A
Cat Ml [1] . . G S S H S T D L M E A M A M G S V E A s Y K C L A A A
Rat Ml [2] . . A S s Q S T D P L E A M A M G S V E A s Y K C L A A A
Rat M2 [2] . . L A p I T S D P T E A A A V G A V E A s F K C C S G A
Rat L & R [3-5] . . A A p L S R D P T E V T A I G A V E A s F K C C A A A
Human L [6] . . A A p L S R D P T E V T A I G A V E A A F K C C A A A
Fig.4. Pyruvate kinase amino acid sequences in the region of the yeast sequence differences (indicated by the asterisks). The yeast se¬
quences are compared with those from chicken muscle [7], cat skeletal muscle isoenzyme Ml [1], rat skeletal muscle isoenzyme Ml [2],
rat kidney isoenzyme M2 [2], rat liver and erythrocyte isoenzymes L and R [3-5], and human liver isoenzyme L [6], Residues that are
identical in four or more sequences are boxed.
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Fig.5. The distribution of non-preferred codons in the AROl, FAS1, HIS4 and TRP5 genes from S. cerevisiae. The unique codons for
methionine and tryptophan are considered to be neutral in this analysis; they do not stop a string of non-preferred codons, nor con¬
tribute to it. The number of consecutive non-preferred codons in a string is plotted against the location of the string within the coding
region. The domain organisation of each coding region is presented above each graph. AROl (diagram adapted from [10]; sequence
published in [15]). FAS1: AC, acetyl transferase; ER, enoyl reductase; DH, dehydratase; MP, malonyl palmityl transferase [16]. HIS4:
A, phosphoribosyl-AMP cycolhydrolase; B, phosphoribosyl-ATP pyrophosphohydrolase; C, histidinol dehydrogenase [17], TRP5: A
and B, alpha and beta domains of tryptophan synthase [18].
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Site-directed mutagenesis as a tool for the study of the allosteric control of pyruvate kinase
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Vruvate kinase EC 2.7.1.40 ' catalyses the reaction
Mj K'
'hosphoenolpyruvate ~ MgADP + H — pyruvate + MgATP
"his is the second ATP-forrrung reaction of glycolysis and is
onsidered to be a major control point for the lower end of
he glycolytic pathway. In most species studied the enzyme is
homotetramer of M. approx. 240000: however, recent
eports [1, 2j suggest that the enzymes from Zvmomonas
nobiiis and Schizosuccharomyces pombe may be dimeric.
In mammalian systems four isoenzymes of pyruvate kinase
re expressed in a tissue-specific manner. The L. R and M2
soenzymes from liver, red blood cell and kidney, respec-
ivelv. are all allosterically regulated by a number of effectors
uch as ATP. fructose 1.6-bisphosphate and gluconeogenic
mino acids. This control prevents a futile loop between the
nzymes of glycolysis and gluconeogenesis in tissues that can
indertake both pathways. The Ml isoenzyme from skeletal
nuscle is not allosterically regulated and displays hyperbolic
:inetics under physiological conditions.
It has recently been shown that the Ml and M2 iso-
nzvmes are encoded by the same structural gene and that
he differences in sequence arise by a tissue-specific mRNA-
plicmg event [3j. Moreover, the sequences of the two iso-
inzymes differ bv only 21 amino acids clustered in two
i-helices which form the major intersubunit contact region
tcross the 1.3-intersubunit interface [4i. It is therefore
uspected that these two a-helices, designated Cal and
7a2, are largely and perhaps solely involved in conferring
he allosteric nature of the M1 isoenzyme because sequences
lutwith this region are identical in the Ml and M2 forms.
The yeast Saccharomyces cerevisiae has only one pyruvate
tinase which is allosterically controlled and is reported to be
tineticaily most like the M2 isoenzyme. The gene has been
:!oned and sequenced [5j and is present on a 7 kbp M/tdlLI
ragment of DNA.
The yeast enzyme has been chosen for the present study
lecause recent developments in the genenc manipulation of
least have made it easy to delete wild-type genes and to
jvere.xpress proteins from high-copy-number vectors, thus
acilitaung purification and subsequent kinetic analysis see
61 for a review .
The crystal structure of the cat Ml isoenzyme has been
esolved to 2.6 A [4j 4nd the sequence of the yeast enzyme
las been modelled into the cat muscle co-ordinates to give
tn approximation of its three-dimensional structure T. H. L.
Turcott A H. Muirhead. Department of Biochemistry. Um-
ersiry of Bristol, personal communication .
Three mutants have been made bv oiigonucleotide-
irected mutagenesis in the 1.3-tntersubumt contact area.
Examination of the yeast structural model shows that serine-
14 from subunit 1 lies directly opposite serine-414 from
ubunit 3. The change of this residue to one bearing a bulky
r charged side chain is expected to force the 1.3-intersub-
rut interface apart, and thus yield a dimeric pyruvate kinase
hich is predicted to be catalvtically active but no longer
tguiated by allostenc effectors. This residue has been
langed to an arginine. a histidine and a proline. A further
Cc2
Fig. 1. A tetramer ofpyruvate kinase
The broken line shows the 1.3-intersubunit interface. Ca!
and Ca2 are indicated.
series of mutations has been designed to look at the catalytic
lysme-269 which is thought to stabilize the phospho inter¬
mediate as it is transferred from phosphoenolpyruvate to
ADP. Lysme-269 has been changed to an arginine and a
histidine to test the effect of moving the positive charge.
All of these mutations have been made at the DNA level
and work is currently underway to overexpress the mutant
proteins in yeast and to analyse their kinetic properties. A
pyk~ strain of yeast has been constructed in our laboratory
by a simple gene disruption technique. Mutants which pro¬
duce active protein can be easily identified by their ability to
rescue the pyk' phenotype of the strain. Active mutants will
be analysed by standard kinetic techniques to determine
alterations in A, and and in their susceptibility to allo¬
steric regulators.
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